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ABSTRACT
Seo, JangDong. Joint models of longitudinal outcomes and informative time.
Published Doctor of Philosophy Dissertation, University of Northern
Colorado, 2015
In longitudinal data analyses, it is commonly assumed that time intervals
for collecting outcomes are predetermined – the same across all subjects – and have
no information regarding the measured variables. However, in practice researchers
might occasionally have irregular time intervals and informative time, which violate
the above assumptions. Hence, if traditional statistical methods are used for this
situation, the results would be biased.
In this study, as a solution, joint models of longitudinal outcomes and
informative time are presented by using joint probability distributions,
incorporating the relationships between outcomes and time. The joint models are
designed to handle outcome distributions from a member of the exponential family
of distributions with informative time following an exponential distribution. For
instance, the Poisson probability density function is combined with the exponential
distribution for count data, as well as the relations between outcomes and time; the
Bernoulli probability density function is combined for binary data; and the Gamma
probability density function is combined when the outcome is waiting time or
survival time. The maximum likelihood parameter estimates of the joint model are
found by using a nonlinear optimization method, and the asymptotic behaviors of
the estimators are studied. Moreover, the likelihood ratio test statistic is computed
for comparing nested models, and the model selection criteria, such as AIC, AICc,
BIC, are found as well.
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Through simulation studies, the maximum likelihood parameter estimates
of the joint models appeared to be multivariate normal as the number of
observations increased. As a result, the likelihood ratio test statistic could be
utilized for model comparisons since the asymptotic normality of the maximum
likelihood estimators has been verified. Also, AIC, AICc, and BIC scores were
calculated as model selection criteria. Furthermore, the computing package using R
was developed to handle the joint models and used to analyze the bladder cancer
data for demonstration purposes.
iii
ACKNOWLEDGEMENTS
First of all, I would like to express my deepest gratitude to my advisor, Dr.
Khalil Shafie, for his excellent guidance, caring, patience, and support, while
writing this dissertation. Without his advice on mathematical procedures and
developing programming, I would not have succeeded. I would also like to thank
my dissertation committee members, Dr. Jay Schaffer, Dr. Trent Lalonde, and Dr.
Heng-Yu Ku, for their helpful criticism and provision of the development of this
dissertation.
I would like to thank my family, my wife, EunGyeong, and my lovely
daughters, GyeongMin and Jean, for all the support they have provided throughout
my studies, including this dissertation. My wife was always there cheering me up
and stood by me through the good and bad times. Without their patience and
support, I would have found it very difficult to overcome the ups and downs during
the study.
iv
TABLE OF CONTENTS
CHAPTER Page
I INTRODUCTION 1
General Notations for Longitudinal Data . . . . . . . . . . . . . . . . . 2
Longitudinal Data Analysis . . . . . . . . . . . . . . . . . . . . . . . . 4
Purpose of the Study . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
Definition of Terminology . . . . . . . . . . . . . . . . . . . . . . . . . 8
Research Questions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
Limitations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
II LITERATURE REVIEW 11
Simple Method Approach . . . . . . . . . . . . . . . . . . . . . . . . . 11
Repeated Measures Analysis with ANOVA . . . . . . . . . . . . . . . . 12
Repeated Measures Analysis with MANOVA . . . . . . . . . . . . . . . 14
Mixed-Effects Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
Marginal Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
Joint Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
III METHODOLOGY 29
Notation and Joint Model . . . . . . . . . . . . . . . . . . . . . . . . . 29
Generalized Linear Model . . . . . . . . . . . . . . . . . . . . . . . . . 30
Joint Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
Model Selection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
Data Simulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
IV RESULTS 50
Simulation Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
Likelihood Ratio Test . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81
Information Criteria . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
Analysis of Bladder Cancer Data . . . . . . . . . . . . . . . . . . . . . 83
V CONCLUSION AND DISCUSSIONS 89
Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
Application of the Joint Models . . . . . . . . . . . . . . . . . . . . . . 91
v
Discussions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
REFERENCES 94
Appendix A Output of the Bernoulli-Exponential Model 98
Appendix B Output of the Poisson-Exponential Model 104
Appendix C R Program for Simulations 110
Appendix D R Program of the Joint Models 124
vi
LIST OF FIGURES
FIGURE Page
1 Outcome Process of the Gaussian-Exponential Model (Subjects) . . . . 54
2 Outcome Process of the Gaussian-Exponential Model (Subjects) . . . . 54
3 Outcome Process of the Gaussian-Exponential Model (Observations) . 55
4 Outcome Process of the Gaussian-Exponential Model (Observations) . 55
5 Time Process of the Gaussian-Exponential Model (Subjects) . . . . . . 57
6 Time Process of the Gaussian-Exponential Model (Subjects) . . . . . . 57
7 Time Process of the Gaussian-Exponential Model (Observations) . . . . 58
8 Time Process of the Gaussian-Exponential Model (Observations) . . . . 58
9 Outcome Process of the Bernoulli-Exponential Model (Subjects) . . . . 60
10 Outcome Process of the Bernoulli-Exponential Model (Subjects) . . . . 61
11 Outcome Process of the Bernoulli-Exponential Model (Observations) . 61
12 Outcome Process of the Bernoulli-Exponential Model (Observations) . 62
13 Time Process of the Bernoulli-Exponential Model (Subjects) . . . . . . 64
14 Time Process of the Bernoulli-Exponential Model (Subjects) . . . . . . 64
15 Time Process of the Bernoulli-Exponential Model (Observations) . . . 65
16 Time Process of the Bernoulli-Exponential Model (Observations) . . . 65
17 Outcome Process of the Poisson-Exponential Model (Subjects) . . . . . 67
18 Outcome Process of the Poisson-Exponential Model (Subjects) . . . . . 68
19 Outcome Process of the Poisson-Exponential Model (Observations) . . 68
20 Outcome Process of the Poisson-Exponential Model (Observations) . . 69
21 Time Process of the Poisson-Exponential Model (Subjects) . . . . . . . 71
22 Time Process of the Poisson-Exponential Model (Subjects) . . . . . . . 71
23 Time Process of the Poisson-Exponential Model (Observations) . . . . 72
24 Time Process of the Poisson-Exponential Model (Observations) . . . . 72
25 Outcome Process of the Gamma-Exponential Model (Subjects) . . . . . 74
26 Outcome Process of the Gamma-Exponential Model (Subjects) . . . . . 75
27 Outcome Process of the Gamma-Exponential Model (Observations) . . 75
28 Outcome Process of the Gamma-Exponential Model (Observations) . . 76
29 Time Process of the Gamma-Exponential Model (Subjects) . . . . . . . 78
30 Time Process of the Gamma-Exponential Model (Subjects) . . . . . . . 78
31 Time Process of the Gamma-Exponential Model (Observations) . . . . 79
32 Time Process of the Gamma-Exponential Model (Observations) . . . . 79
vii
LIST OF TABLES
TABLE Page
1 General Layout of Longitudinal Data . . . . . . . . . . . . . . . . . . . 3
2 Variances and link functions . . . . . . . . . . . . . . . . . . . . . . . . 31
3 Parameter Values for Simulations . . . . . . . . . . . . . . . . . . . . . 46
4 Simulation Designs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
5 Outcome Process of the Gaussian-Exponential Model: p-values of the
Multivariate Normality Tests . . . . . . . . . . . . . . . . . . . . . . . 56
6 Time Process of the Gaussian-Exponential Model: p-values of the
Multivariate Normality Tests . . . . . . . . . . . . . . . . . . . . . . . 59
7 Outcome Process of the Bernoulli-Exponential Model: p-values of the
Multivariate Normality Tests . . . . . . . . . . . . . . . . . . . . . . . 63
8 Time Process of the Bernoulli-Exponential Model: p-values of the
Multivariate Normality Tests . . . . . . . . . . . . . . . . . . . . . . . 66
9 Outcome Process of the Poisson-Exponential Model: p-values of the
Multivariate Normality Tests . . . . . . . . . . . . . . . . . . . . . . . 70
10 Time Process of the Poisson-Exponential Model: p-values of the
Multivariate Normality Tests . . . . . . . . . . . . . . . . . . . . . . . 73
11 Outcome Process of the Gamma-Exponential Model: p-values of the
Multivariate Normality Tests . . . . . . . . . . . . . . . . . . . . . . . 77
12 Time Process of the Gamma-Exponential Model: p-values of the
Multivariate Normality Tests . . . . . . . . . . . . . . . . . . . . . . . 80
13 Model Selection Criteria for the Bernoulli-Exponential Model . . . . . 85
14 Model Selection Criteria for the Poisson-Exponential Model . . . . . . 86
15 Coefficients of the Latent Effect Model . . . . . . . . . . . . . . . . . . 87
16 Coefficients of the Poisson-Exponential Model . . . . . . . . . . . . . . 87
viii
Dedicated To
My Wife,
Lovely Daughters,
and Parents
ix
1CHAPTER I
INTRODUCTION
The term “repeated measurements” is used to define outcomes measured at
multiple time points on the same subjects or experimental units. When outcomes
are collected for a relatively long period of time on the same subjects to evaluate
the changes over time, the term “longitudinal data” is a common name instead of
repeated measurements. In general, repeated measurement data are treated as a
part of longitudinal data (Davis, 2002). Longitudinal study design is believed to
be more powerful than traditional cross-sectional design in terms of the ability to
capture the within-subject effect, by excluding the between-subject variability and
investigating any trend or pattern on the changes for subjects. In addition, due to
the exclusion of between-subject variability, the estimate of within-subject effects
can be calculated more accurately (Fitzmaurice, Laird, & Ware, 2004; Hedeker &
Gibbons, 2006).
Despite the advantages of the longitudinal design over the cross-sectional
design, there are some barriers to analyzing the longitudinal data due to its
complexity of data structure. Firstly, the measurements are assumed to be
correlated, in general, with each other since the outcomes are collected repeatedly
at multiple time points from the same subjects. The traditional approaches, such as
simple method, the Analysis of Variance (ANOVA), or Multivariate Analysis of
2Variance (MANOVA), have an assumption that outcomes are independent of each
other, ignoring the correlation among outcomes, which cannot be true in
longitudinal designs. Secondly, due to the long duration of a study, the researcher
has difficulties controlling the subjects or the whole experiment. Therefore, very
often the final data may turn out to be incomplete or unbalanced, or has missing
data due to attrition, which is also adding to difficulties in analyzing the data, even
though the researcher did not intend it at the beginning of the study.
Many methods have been developed and proposed attempting to handle the
problems, but most of the methods are limited to cases with complete data
(Hedeker & Gibbons, 2006), or normally distributed outcomes with balanced
complete data (Davis, 2002). That is why nowadays the mixed-effects model or the
generalized estimating equation (GEE) model is getting popular, but many
researchers still also use the traditional methods due to the simplicity of
computation, in spite of their drawbacks. Therefore, selection of a method for one’s
longitudinal study is totally up to the researcher’s subjective judgement based on
the purpose of the research.
General Notations for Longitudinal Data
Notations to represent longitudinal data used in this study may slightly
vary based on the methods introduced in each chapter, but the general notations
are similar throughout this study. The number of subjects, or experimental units, is
denoted by m and the subject is denoted by i, which are expressed as
i = 1, . . . ,m.
3Time point for the ith subject is denoted by j and the number of outcomes of the
ith subject, which are written as
j = i, . . . , ni.
If a dataset is balanced and complete, all subjects will have the same
number of outcomes at the same time points, then j can be simplified by
j = 1, . . . , n. The advantage of using ni is that it allows each subject to have a
different number of outcomes. The outcomes at the jth time point for the ith
subject with ni outcomes can be expressed by
yij = (yi1, . . . , yini)
′.
A general layout of longitudinal data is described in Table 1 below.
Table 1
General Layout of Longitudinal Data
Subject Occasions
1 y11 y12 . . . y1j . . . y1n1
2 y21 y22 . . . y2j . . . y2n2
...
...
...
...
...
i yi1 yi2 . . . yij . . . yini
...
...
...
...
...
m ym1 ym2 . . . ymj . . . ymnm
A balanced or complete data structure is a special case of longitudinal data since
each subject can have a different number of measurements.
4Longitudinal Data Analysis
Many approaches have been developed in order to handle longitudinal data.
However, none of those can take care of all potential problems that may arise in the
analysis for longitudinal data, so researchers have to make a decision about which
approach to use based on their research questions, purpose of study, and data
collection method.
For example, a simple method was introduced by Student (1908). In his
study there were two outcome variables, such as pretest and posttest, and then a
new variable called the summary variable was calculated by taking the difference
between the pretest and posttest. Then, the summary variable was tested to
determine if the average of the summary variable was equal to zero. This method
will be enough when there are only two outcome variables at two different time
points. The simple method has been applied by many researchers due to its
simplicity of calculation.
Currently, one of the most commonly used methods might be the Analysis
of Variance (ANOVA) or Multivariate Analysis of Variance (MANOVA) method.
These methods are more advanced techniques than the simple method and easy to
apply to longitudinal data. The two methods, however, have unrealistic
assumptions, such as equal variance structure and equal predetermined time
intervals to all subjects; moreover, data should be complete and balanced.
Other methods called mixed-effects model and generalized estimating
equation (GEE) model are also used with highly math-oriented or computer-based
5techniques, attempting to handle the special characteristics of longitudinal data:
correlation among outcomes, unequal time points for each subject, and unbalanced
data structure. Although these methods were developed to obtain more accurate
estimations of changes over time, they are known to be computationally very
complicated and need more computer programming. Despite computational
difficulties, these approaches are being widely used, especially in the fields of
biology, pharmaceuticals or physics due to the accuracy and efficiency of the
estimation. Moreover, the GEE approach was developed to handle binary and
count outcomes as well as continuous outcomes; therefore, the GEE model is very
useful when the outcome is binary or count. The common drawback of the GEE
and mixed-effects models is that time is still fixed or predetermined by the design.
So, when time points are irregular and data are unbalanced, estimators may be
biased (Lin, Scharfstein, & Rosenheck, 2004). Researchers are still putting in a lot
of effort to find better methods. For instance, when time is informative, which
means that the next time points for collecting measurements are adaptively
determined based on current outcomes for each subject, the methods mentioned
above are not appropriate.
Purpose of the Study
Most of the currently existing methods have now been introduced, and
some disadvantages have been described as well as advantages. One common aspect
to all the methods above is that time is fixed or predetermined before the study. In
general, longitudinal study is conducted for a relatively long period of time to find
6if there is any specific trend over time. If time is not fixed or cannot be determined
by a researcher – since each subject’s next time point is decided based on current
outcome, causing irregular time intervals for individuals – estimations by using the
methods above may be biased. For instance, individuals may follow different
measurement schedules based on their prior health outcomes since patients who
have poorer health outcomes will be asked to visit for checkups more often;
therefore, patients will not share the common time occasions; instead each patient
will follow their own schedule for visiting the clinic depending on their own prior
health outcomes (Lipsitz, Fitzmarice, Ibrahim, Gelber, & Lipshultz, 2002). Since
the main purpose of this study was to develop a model to handle the situation
described above, namely informative schedule data, all the methods mentioned so
far do not work for this study.
Fortunately, some researchers have introduced a new approach, named joint
model, which is combining longitudinal data and the time-related factor. There are
multiple articles under the name of the joint model (Henderson, Diggle, & Dobson,
2000; Kim, Zeng, Chambless, & Li, 2012; Liang, Lu, & Ying, 2009; Lin et al., 2004;
Lipsitz et al., 2002; Qiu, Stein, & Elston, 2013). Some of the articles are about the
joint model of longitudinal data and survival outcome, and some are about the
joint model of longitudinal data and informative time. Fundamentally, the joint
model is based on the joint distribution of outcomes and the time related factor
with maximum likelihood estimation. As introduced, the joint model can be
applied to any kind of situation. Estimation by using the joint model produces
more precise results (Qiu et al., 2013). Nonetheless, one fact in common is that
7even though they are dealing with the joint models, the situations they are
studying are different from each other. For that reason, if any researcher who wants
to adapt his/her joint models should be careful of assumptions since all the joint
models were built for different situations.
For example, Bronsert (2009) presented a joint model, named
Gaussian-Exponential model, in which normally distributed longitudinal responses
and intermittent times following an exponential distribution are combined, and he
showed the joint model has a very good ability for longitudinal data analysis
compared to the mixed-effects model in his simulation study. Bronsert calculated
the parameter estimates of the joint model, omitting a procedure checking the
properties of the estimators, such as multivariate normality. Later, Lin (2011)
extended Bronsert’s (2009) study and showed that the parameter estimates
maintain the property of multivariate normality, and the joint model can be an
alternative method for analyzing longitudinal data. Also, Lin studied on how to
calculate the scores for model selection criteria, such as the Akaike information
criterion (AIC), the Akaike information criterion with correction (AICc), the
Bayesian information criterion (BIC), and likelihood ratio test. A limitation of
these studies is that the model incorporates informative time and normally
distributed longitudinal responses only.
Research interest of the current study was developing joint models of
longitudinal outcomes following the exponential family of distributions and
informative time. Thus, this study mainly focused on verifying (1) if the joint
model developed by Bronsert and tested by Lin can be extended and (2) if the
8parameter estimates of the extended joint models maintain the asymptotic
multivariate normality, when the outcome distribution is from a member of the
exponential family of distributions.
Definition of Terminology
Terminology used throughout this study are described below.
Longitudinal Data is a set of outcomes measured at multiple time points on
the same subjects over a given time duration. In general, time points are
predetermined by researchers before outcomes are collected.
Informative Time is used to describe the fact that the next time point for
collecting a response is determined by the current outcome. Thus, all subjects may
not share the common set of time intervals.
Informative Schedule Data is a set of measurements collected repeatedly
from the same subjects for a given time duration. The outcomes are measured
based on the informative time for each subject determined by the previous
outcomes.
Outcome Process is a set of measurements collected repeatedly at multiple
time points for each subject.
Counting Process is a stochastic process with values that are integer,
increasing, and positive in which the values represent arbitrary time points for
collecting responses for each individual.
9Research Questions
Q1 Can the joint model (Gaussian-Exponential model) developed by
Bronsert (2009) and tested by Lin (2011) be extended to longitudinal
outcomes following the exponential family of distributions?
Q2 Do the maximum likelihood estimators of the joint models obtain
asymptotic normality?
Q3 Can the likelihood ratio test be conducted to compare the fit of two
models?
Q4 Can the model selection criteria, such as AIC, AICc, or BIC, be
developed to compare models?
If the answer to Research Question One says that the joint models are not
appropriate for longitudinal outcomes with the exponential family of distributions
and informative schedule data other than normally distributed outcomes, then the
rest of the research questions can not be answered.
Limitations
The following limitations must be considered before any researcher is
willing to take advantage of this study.
1. This study is limited to outcomes with the exponential family of distributions
with a single response variable; therefore, the models should not be applied to
any study with multivariate responses
2. In this study, time is assumed to be exponentially distributed. If any other
distribution other than the exponential distribution is believed to be
appropriate, applying the joint models should not be considered with caution.
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Conclusion
One of the greatest advantages of longitudinal data analyses is that it can
detect changes over time. Most of the analyzing methods introduced above are
treating time as a fixed factor that is predetermined by researchers at the beginning
of the study. In some cases, time intervals, however, are decided based on the
previous outcomes. In that situation, approaches mentioned before cannot be used
and will generate biased estimators, if used. Therefore, as a new model, the joint
model was presented by Bronsert (2009), combining normally distributed
longitudinal responses and informative time. Bronsert used maximum likelihood
estimation to compute the parameter estimates. Then, the joint model was
extended by Lin (2011). He verified that the maximum likelihood estimators of the
joint model obtain multivariate normality. Also, Lin proposed the likelihood ratio
test statistic, AIC, AICc, and BIC as model selection criteria. The assumptions in
their studies are that longitudinal data are normally distributed and time is
exponentially distributed.
Hence, questions arose: what if the outcomes are not assumed to follow a
normal distribution; what if the outcomes have any other types, for instance, binary
or count outcomes? Also, if the joint model is extended to any other types of
outcomes, do the parameter estimates of the extended joint models still keep
asymptotic normaltiy? Thus, this study focused on extending their joint model to
the exponential family of distributions and checking the multivariate normality
assumption of the estimators of the extended joint models.
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CHAPTER II
LITERATURE REVIEW
Multiple methods have been developed due to its complexity of analysis
and used to analyze longitudinal data. In this chapter, commonly used methods
and previously studied joint models combining informative time and outcomes are
discussed.
Simple Method Approach
The purpose of longitudinal studies is to detect changes between outcomes
measured at different time points on the same subjects. One of the elementary
methods was introduced by Student (1908), including outcomes measured at two
time points for each subject. In the analysis, the differences between outcomes
measured at two different time points on the same subjects were used to determine
the change over time. The idea of the simple method is to reduce the multivariate
measurements into a single measurement ignoring the correlation between repeated
measurements.
A well-known example of this type of method is the dependent two sample
t-test. This method can be simply applied when there are two outcomes, but
generally in longitudinal studies, multiple observations at multiple time points are
collected. However, due to the simplicity of the application, this approach has been
commonly used with different names, such as the summary-statistic approach
12
(Frison & Pocock, 1992; Dawson, 1994), the response feature analysis (Crowder &
Hand, 1990), or the derived variable (Diggle, Heagerty, Liang, & Zeger, 2002).
For example, the summary statistic could be the coefficient of the regression
line for each subject. The summary statistic is used to test whether or not the
average of the summary measurements differs from zero. However, the results of the
analysis will be misleading if a wrong summary measurement is selected that does
not represent an individual trend (Davis, 2002). That means the success of the
analysis depends on the selection of summary measurements. Moreover, when time
intervals are not equal across all subjects, the summary variable does not satisfy
the homoscedasticity assumption (Diggle et al., 2002). Therefore, this
summary-statistic approach is not appropriate to be used in this study with
longitudinal informative schedule data.
Repeated Measures Analysis with ANOVA
When outcomes are from a normal distribution satisfying the assumptions
of independence and homogeneity of variance, traditional univariate ANOVA can
be simply applied. Additionally, for repeated measures ANOVA, the assumption of
sphericity must be met also. Sphericity is sometimes called compound symmetry,
also known as homogeneity of covariance. Sphericity is that the variance of
difference between any two levels of within-subjects factor is the same to any
pairwise combination. In general, it is very difficult that longitudinal data meet the
assumptions of independence and homogeneity of variance. In order to test
sphericity assumption, Mauchly’s test is generally used, but this test is not powerful
13
for small sample sizes and sensitive to non-normality; therefore, Mauchly’s test is
not practical (Davis, 2002). Another approach using adjusted degrees of freedom
has been introduced by Greenhouse and Geisser, and Huynh and Feldt when the
sphericity assumption is violated, but these are too conservative, which increases
Type II error (Davis, 2002).
In repeated measures ANOVA model, occasions of measurements are
treated as within-subject effects, so the model becomes
Y ij = X
′
ij + bi + eij, (1)
where X
′
ij is the design matrix, bi is the random subject-specific effect, and eij is
the individual-specific measurement error (Fitzmaurice et al., 2004). In this model,
there are two sources of variation; one is within-subject variation, σ2b , and the other
is between-subject variation, σ2e . Based on the information for variations above, the
covariance structure of the model, known as compound symmetry, becomes
Cov(Y i) =

σ2b + σ
2
e σ
2
b σ
2
b · · · σ2b
σ2b σ
2
b + σ
2
e σ
2
b · · · σ2b
σ2b σ
2
b σ
2
b + σ
2
e · · · σ2b
...
...
... · · · σ2b
σ2b σ
2
b σ
2
b · · · σ2b + σ2e

. (2)
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The covariance structure shows that the variance for each occasion is equal to σ2b +
σ2e . Therefore, the correlation between all pairs of measures is
Corr(Y ij,Y ik) =
σ2b
σ2b + σ
2
e
, j 6= k. (3)
Commonly, correlation between measurements tends to be stronger when
they are closer in time, and the correlation decreases when they are further away
from each other in time; therefore, constant correlation between two measurements
is not realistic. In addition, it is assumed that all subjects have an equal number of
measurements at fixed time points since the repeated measures ANOVA approach
was designed to handle experimental studies (Fitzmaurice et al., 2004). Due to
these unrealistic assumptions, the repeated measures ANOVA model is
inappropriate for this study on informative time and non-normal outcomes.
Repeated Measures Analysis with MANOVA
When the assumptions are violated for repeated measures ANOVA,
MANOVA based on Hotellings T 2 is an alternative way to handle repeated
measures since the sphericity assumption is not necessary. Also, it can handle
multiple response variables simultaneously, but MANOVA reduces the power of
analysis (Vincent, 2005). A general idea of the MANOVA approach is followed
below.
For instance, we have a vector of responses from the ith subject at time j
yi = (yi1, yi2, . . . , yini)
′,
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where i = i, . . . ,m and j = 1, . . . , ni, and yi is from Nt(µ,Σ). To test the
hypothesis of H0 : µ1 = µ2 = · · · = µt, y∗ij = yij − yi,j+1 for j = 1, . . . , t − 1 is
obtained. The y∗i = (y
∗
i1, . . . , yi,t−1)
′ vectors are random samples from Nt−1(µ∗,Σ∗),
where
µ∗ = (µ1 − µ2, µ2 − µ3, . . . , µt−1 − µt)′. (4)
By using Hottelling’s T 2,
T 2 = ny¯∗
′
S∗−1y¯∗ ∼ T 2
t−1,n−1,nµ∗′Σ∗−1µ∗ . (5)
The test statistic F ,
F =
n− t+ 1
(n− 1)(t− 1)T
2, (6)
has a Ft−1,n−t+1 distribution if H∗0 : µ
∗ = (0, . . . , 0)′ holds (Davis, 2002).
One of the advantages of using MANOVA approach, instead of repeated
measures ANOVA, is that it can handle repeated measurements at multiple time
points since MANOVA was originally designed to deal with multiple response
variables (Fitzmaurice et al., 2004). The other advantage is that the assumption of
sphericity is not needed while it still assumes the multivariate normality (Davis,
2002; Hedeker & Gibbons, 2006). However, MANOVA method itself has multiple
shortcomings. One drawback is that the covariance matrix with t × t must be
estimated. When t is large, numerous degrees of freedom to estimate covariance
parameters, t(t − 1)/2, will be lost. Therefore, it causes power to decrease,
especially when F has small degrees of freedom for the denominator (Davis, 2002).
Secondly, like ANOVA, MANOVA approach also can be used only if time points are
16
fixed across all subjects (Hedeker & Gibbons, 2006). However, in longitudinal
studies with informative time, each subject may have different sets of time points.
Thirdly, MANOVA cannot handle missing data like ANOVA. Due to these
restrictions, subjects with missing data will be excluded in the analysis, which
causes loss of a large amount of information in the data (Fitzmaurice et al., 2004;
Hedeker & Gibbons, 2006). In other words, MANOVA cannot handle unbalanced or
incomplete data. Hedeker et. al.(2006) named it “the Achilles heel of the
MANOVA model for repeated measurements” (p. 34). A complete dataset is
unrealistic in longitudinal studies; therefore, it can be used only in limited
situations. Despite benefits of using MANOVA model over repeated measures
ANOVA, it is not considered for this study on informative time and non-normal
outcomes because of these drawbacks.
Mixed-Effects Model
Due to the unrealistic assumptions, such as non-missing, sphericity, and
complete data structure in ANOVA and MANOVA models the use of these
traditional methods are restricted to certain cases and must be interpreted with
caution. The mixed-effects model is an univariate regression analysis on correlated
responses (Davis, 2002). One main advantage of using the mixed-effects model is
that it can handle missing data and incomplete data that are problematic in
ANOVA and MANOVA analyses for repeated measures. Due to its flexibility, the
mixed-effects model has been studied by and became popular among many
statisticians for longitudinal data analyses these days (Lindstrom & Bates, 1990;
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Pinheiro & Bates, 1995, 2000). Also, there are a couple more benefits that make
the mixed-effects model popular for repeated measures analyses. Firstly, traditional
methods, such as ANOVA and MANOVA, assume that all subjects would have the
outcomes measured at the same number of fixed time points, but the mixed-effects
model does not need this assumption. For this reason, any subjects with missing
data or incomplete data can be included in the analysis, which means it will
increase statistical power. It is not necessary for each subject to be measured at the
same time points since time is treated as a continuous variable in the mixed-effects
model (Hedeker & Gibbons, 2006). Secondly, since the mixed-effects model is an
extension of repeated measures ANOVA, one can measure the average changes
across time. Moreover, by including subject-specific effects in the model as a
random effect, the model can detect individual trajectories. For these reasons, the
mixed-effects model has become popular for longitudinal data analyses. The
average responses across time for each subject is named as a fixed effect, while a
subject-specific effect, which is unique to each subject, is called a random effect.
Literally, the mixed-effects model combines both fixed effects and random effects
(Fitzmaurice et al., 2004).
The mixed-effects model has been used with a variety of different names:
random effects model (Diggle et al., 2002; Fitzmaurice et al., 2004; Laird & Ware,
1982), multilevel model (Goldstein, 2011; Nash & Varadhan, 2011), hierarchical
model (Lee & Nelder, 1996; Raudenbush & Bryk, 2002), and random coefficient
model (Leeuw & Kreft, 1986). Using matrix notations, the mixed-effects model for
a vector of ni × 1 responses for the ith subject can be written as
18
yi = X iβ +Ziγi + i, (7)
where
yi = (yi1, . . . , yini)
′ is the vector of responses for the ith subject at time point
j for j = 1, . . . , ni,
X i is the ni × p covariate matrix for the ith subject,
β is the p× 1 vector of fixed effects,
Z is the ni × r design matrix for random effects,
γ is the r × 1 vector of random effects, and
 is the ni × 1 vector for error with the assumptions of
i = N(0, σ
2Ini) and γi = N(0,Σγ). (8)
The variance-covariance matrix of the model becomes
Cov(yi) = Cov(X iβ +Ziγi + i)
Cov(yi) = Cov(Ziγi) + Cov(i)
Cov(yi) = ZiGZ
′
i + Cov(i).
(9)
The model can be rewritten as
Cov(yi) = ZiGZ
′
i + σ
2Ini , (10)
since Cov(i) = σ
2Ini , which has the diagonal elements of the variance-covariance
matrix with all zeros for the entries outside the main diagonal (Fitzmaurice et al.,
2004). The mixed-effects model can be presented in a multilevel form for a better
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explanation of each subject’s effect on their observations (Hedeker & Gibbons,
2006).
For example, when there is time and one factor in the model, the level-1
model, which represents within-subjects, becomes
yij = pi0j + pi1jTimeij + ij. (11)
The level-2 model, which represents between-subjects, is
pi0j = β00 + β01Groupi + µ0j
pi1j = β10 + β11Groupi + µ1j,
(12)
where
ij ∼ N(0, σ2) and
µ0j
µ1j
 ∼ N

0
0
 ,
τ00 τ01
τ10 τ11.

 . (13)
The linear format of the combined level-1 and level-2 models becomes
yij =β00 + β01Groupj + β10Timeij + β11GroupjTimeij
+ µ0j + µ1jTimeij + ij.
(14)
In the linear model, β00, β01, β10, and β11 are the coefficients for the fixed effects,
and µ0j, µ1j, and ij are the random effects. A description of each term in the
model is as follows.
yij is the outcome for subject i measured at time point j,
β00 is the average intercept for all subjects,
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β01 is the average difference in pi0j for a unit change in level-2 predictor,
β10 is the average of the level-1 slope,
β11 is the average difference in pi1j for a unit change in level-2 predictor,
pi0j is the intercept of the trajectory of subject i,
pi1j is the slope of the trajectory of subject i,
µ0j is the unique contribution of each j to the mean response on time point j,
µ1j is the unique contribution of each j to the slope on time point j
(Singer & Willett, 2003). As it can be seen in the model, because time points are
from j = 1 to ni, the model can include all outcomes measured at different time
points in the analysis. Additionally, the model allows for each subject to be
measured at different schedules of time points, which means the model can handle
missing data, incomplete data, or unbalanced data (Hedeker & Gibbons, 2006).
Parameters of variance components can be estimated by using maximum
likelihood estimation, which needs an iterative numerical solution of a nonlinear
optimization procedure (Davis, 2002). There are many statistical computing
software that can calculate paramteres of covariance components. Also, these
softwares provide a variety of types of covariance structures for the G matrix, such
as compound symmetry, unstructured, first-order autoregressive, or Toeplitz, etc.,
as an initial value of the iteration. An alternative approach instead of the
maximum likelihood estimation is the restricted maximum likelihood (REML)
approach. This approach was introduced since the maximum likelihood estimation
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method generates a somewhat baised solution when the design is unbalanced
(Patterson & Thompson, 1971).
Despite many advantages of the mixed-effects model for longitudinal data,
this model also has some drawbacks. One is that the covariance matrix structure
of the yi vector is nonstationary. For example, when outcomes are collected from
the same subjects at equally spaced time points, j = i, . . . , n, the variance and
covariance become respectively
V ar(yij) = σ
2
α + 2jσαβ + j
2σ2β + σ
2,
Cov(yij, yij′) = σ
2
α + (j + j
′)σαβ + jjσ2β.
(15)
Consequently, general trends at time point j are (1) the V ar(yij) increases after
time j when j > −σαβ/σ2β, and (2) the V ar(yij) decreases up to time j when
j < −σαβ/σ2β (Davis, 2002). However, this result is not realistic in longitudinal
data. The other drawback shown in a simulation study is that the quality of the
mixed-effects model is greatly affected by the choice of variance-covariance matrix
structure (Davis, 2002). Moreover, in the mixed-effects model, time is still treated
as fixed; therefore, the mixed-effects model is not an appropriate method for this
study on informative schedule data.
Marginal Model
Liang and Zeger (1986) introduced the marginal model approach using the
generalized estimating equations (GEE) method to analyze repeated measurements,
which is an extension of the generalized linear model to longitudinal data analyses
using quasilikelihood estimation. The terminology of the marginal model is referred
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to as the population-average model, meaning that the model for the mean response
is not affected by any random effects or previous responses, and instead solely
depends on the covariate. The marginal model does not need any assumptions for
the distribution of outcomes; it depends only on assumptions for the mean of
responses, so the marginal model can be used for binary or count as well as
continuous outcomes. However, in general, the GEE model is very useful for
categorical and count outcomes (Hedeker & Gibbons, 2006). The other advantage is
that subjects do not need to have the same number of outcomes measured at the
same time periods (Fitzmaurice et al., 2004).
A brief introduction to GEE method is as follows. The expected mean of
each response given covariate, µij = E(yij|Xij), can be rewritten with a link
function as
g(µij) = X
′
ijβ. (16)
The variance of yij given the covariates becomes
V ar(yij) = v(µij)φ, (17)
where v(µij) is a known variance function, which is the relationship between the
mean and the variance, expressing the variance as a function of the mean, and φ is
a known or to be estimated scale parameter. The link and variance functions for
different distributions of outcomes are shown below. The normally distributed
outcomes with the identity link function has
g(µij) = µij = X
′
ijβ, v(µij) = 1, and V ar(yij) = v(µij)φ = φ. (18)
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For binary outcomes,
g(µij) = log
(
µij
1− µij
)
= X ′ijβ, V ar(yij) = µij(1− µij), and φ = 1. (19)
For Poisson outcomes,
g(µij) = log(µij) = X
′
ijβ, V ar(yij) = µij, and φ = 1. (20)
The last component of the GEE model is the working correlation matrix Ri(a) for
each yi = (yi1, . . . , yini)
′ with dimension of ni × ni, which is called the working
correlation between yij and yij′ . This correlation structure will vary based on a
pattern of relationships of the repeated measurements. For example, when no
correlation is assumed, R(a) = I, which is the identity matrix with the equal
correlations, Rij(a) = ρ for any i 6= j, the correlation structure is called
exchangeable, also known as compound symmetry. The working variance-covariance
matrix for yi becomes
V (a) = φA
1/2
i Ri(a)A
1/2
i , (21)
where Ai is a diagonal matrix with v(µij) as the jth diagonal element. Finally, the
GEE estimates of the parameter vector β can be obtained by solving
U(β) =
n∑
i=1
(
∂µi
∂β
)
[V i]
−1(yi − µi) = 0p (22)
(Singer & Willett, 2003). To get the vector of parameters β, a numerical iterative
method is needed by using the quasilikelihood method (Davis, 2002).
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Since there is no distributional assumption, the GEE model provides a very
flexible approach to estimate the mean and pairwise correlations among repeated
measures; also, it can handle missing data and unbalanced data (Fitzmaurice et al.,
2004). The GEE model also has some drawbacks. Firstly, the estimation of β used
in the GEE model is less efficient compared to the maximum likelihood-based
estimation due to no assumption on the distribution (Fitzmaurice et al., 2004).
Secondly, the GEE model is not sensitive to misselection of variance-covariance
structure; therefore, when research questions are not about variance-covariance
structure, the GEE model can be a good option to the researcher. However, if the
researcher’s interest is in the estimation of the variance-covariance structure, the
GEE model will not be a good selection. Thirdly, even though complete data across
time for subjects is not required in the GEE model, the model assumes all time
points are fixed, and if there are any missing responses, it must be missing
completely at random (MCAR) (Hedeker & Gibbons, 2006). The assumption of
fixed time points is unrealistic and does not fit this study on informative schedule
data. Fourthly, parameter estimates of βˆ are not consistent to estimate β when
time-varying covariates are involved in the regression model (Pepe & Anderson,
1994). Despite all the advantages of the GEE model, in this study, time points are
considered to be not fixed. That is why the GEE model is not considered to be a
potential candidate for this study.
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Joint Model
Currently, a new approach named the joint model is getting popular in an
attempt to handle irregular measurement occasions in the analysis, which is
combining longitudinal data and time or any other factors that the researcher is
interested in (Henderson et al., 2000; Kim et al., 2012; Liang et al., 2009; Lin et al.,
2004; Lipsitz et al., 2002; Qiu et al., 2013; Wu, Liu, Yi, & Huang, 2012). The joint
model uses maximum likelihood estimators of its joint distribution.
For example, Liang et al., (2009) presented a joint model of longitudinal
data with informative observation times via latent variables to handle highly
irregular time points and longitudinal outcomes. Their model is for longitudinal
outcomes and censoring or dropout time under the assumption that censoring time
is non-informative; in addition, outcomes are measured only at the dropout time.
That is the difference from this current study that involves multiple time points.
Lipsitz et al. (2002) presented a joint model for longitudinal data. The
joint model assumes that time points are not fixed and dependent on previous
outcomes, and the repeated measurements are supposed to follow a multivariate
normal distribution. The likelihood function of the joint model consists of two
components: one for the counting process, the other for the outcome process. The
outcome process is determined by yi(t) = µi(t) + i(t), where µi(t) is the marginal
mean at time t and i(t) is a Gaussian process. The counting process is the number
of measurements on the ith subject by a continuous time point. The joint model
was developed based on the idea that time points are dependent on previously
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observed data only, not the times where outcomes are measured. The advantage of
the separation of likelihood function, such as the counting process and the outcome
process, is the simplicity of the calculation of the maximum likelihood estimators,
since the counting process can be ignored when using the likelihood based
estimation for the outcome process, or vice versa.
Bronsert (2009) presented his joint model to handle informative time and
normally distributed longitudinal outcomes. Bronsert’s Gaussian-Exponential
model comes with assumptions of a normal distribution for the outcome process
and an exponential distribution for informative time. The main difference between
Bronsert’s joint model and the joint models above is that repeated outcomes are
dependent on previous outcomes and current time points. That is given by
fθi(yi, ti) =
1√
2piσ2
exp
(
−1
2
(yi1 −X ′i1β)2
σ2
)
× f(ti1)
×
ni∏
j=2
{
1√
2piσ2
√
1− ρ2i
exp
(
−1
2
(yij − γtij − ϕiyij−1 −X ′ijβ)2
σ2(1− ρ2i )
)
· exp(α + δiyij−1) · exp(−eα+δiyij−1tij)
}
,
(23)
where
β is the effect of the independent variables on outcomes,
f(ti1) is the initial time point for the ith subject,
ϕ is the effect of the previous outcome on the mean response of the current
outcome,
γ is the effect of current time on the mean response,
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α is the constant parameter for the time process,
δ is the effect of the previous outcome on the mean time, and
X is the design matrix.
f(ti1) is a distribution for an initial time point, and it is assumed that the
distribution of f(ti1) does not affect any parameters. The maximum likelihood
estimators Θ were calculated from the log-likelihood function of the
Gaussian-Exponential model by using the nonlinear optimization algorithms called
NLPDD Call in SAS/IML that uses the double dogleg optimization method.
Bronsert’s study showed only parameter estimates without testing if the estimators
can be usable for hypothesis testing, which assumes the normality assumption.
Later, Lin (2011) adapted and modified Bronsert’s Gaussian-Exponential
model. Lin’s modified model is
fθi(yi, ti) =
1√
2piσ2
exp
(
−1
2
(yi1 −X ′i1β)2
σ2
)
× f(ti1)
×
ni∏
j=2
{
1√
2piσ2
exp
(
−1
2
(yij − γtij − ϕiyij−1 −X ′ijβ)2
σ2
)
· exp(α + δiyij−1) · exp(−eα+δiyij−1tij)
}
.
(24)
The only difference is that ρ2i is not included in Lin’s model. The term of ρ
2
i was
used to account for the relationships between two outcome variables at two time
points in Bronsert’s model. Lin believed that it is redundant since there is another
term to take care of the correlation, so ρ2i is not included in the modified model.
The modified model was used in this study to test if the model can be extended
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when the responses have the exponential family of distributions with informative
time.
Conclusion
In general, the main purpose of longitudinal data analyses is to capture the
changes over time. Currently, multiple methods are being used to fulfill this
purpose, and most of them are working well in finely-designed experiments,
especially when all subjects share the common fixed time points. One common
assumption to all the models, except the joint models discussed in this chapter, is
that time intervals are predetermined by the researcher or previous studies. In
practice, sometimes time points must be determined based on prior outcomes,
which means individuals may have different sets of time points. As a result of
irregular measurement occasions for each subject, traditional methods may not be
the best for this longitudinal design with informative schedule data, since
traditional methods assume time to be fixed. The joint model does not require time
to be fixed. Thus, in the current study, the joint model by Bronsert and Lin was
investigated to find if the model could be extended when repeated outcomes have
the exponential family of distributions.
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CHAPTER III
METHODOLOGY
The traditional models can be used for informative schedule data, but the
results of analyses may not be usable because the traditional approaches assume
time is fixed. The joint model by Bronsert (2009) and Lin (2011) was developed
under the assumption that outcomes follow a normal distribution and time follows
an exponential distribution. In this study, Bronsert and Lin’s joint model was
adapted and modified to find if the parameter estimates of the extended joint
models satisfy the normality assumption when the distribution of outcomes is a
member of the exponential family of distributions.
Notation and Joint Model
The outcome for the ith subject measured at the jth time point refers to
yij; therefore, the ith subject has yi = (yi1, yi2, . . . , yini)
′ collected at
ti = (ti1, ti2, . . . , tini)
′. The joint distribution of outcomes and time points becomes
fΘ(yi, ti) = fΘ(yi|ti) · fΘ(ti), (25)
where Θ is a vector of unknown parameters. A general model can be derived by
using this joint distribution of yi and ti. Therefore, the general model under the
assumptions that the current outcome is dependent on the one-step prior outcome
(yij−1), current outcome (yij), and current time point (tij) becomes
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fΘ(yi, ti) = fΘ(yi1|ti1) · fΘ(ti1) ·
ni∏
j=2
fΘ(yij|tij, yij−1) · fΘ(tij|yij−1). (26)
Based on this general model, a joint model was developed for each member of the
exponential family of distributions, while assuming time to follow an exponential
distribution.
Generalized Linear Model
The purpose of this study was to develop joint models that can handle
outcomes from the exponential family of distributions. The generalized linear
model provides a unified class of models of regression analysis, regardless of discrete
or continuous outcomes (Dobson, 2001; Fitzmaurice et al., 2004; McCullagh &
Nelder, 1983, 1989; Nelder & Wedderburn, 1972). The generalized linear model has
three components: a random component, a systematic component, and a link
function. The random component identifies the distribution of outcome variable.
The generalized linear model assumes that the outcome variable has a
probability distribution from the exponential family of distributions. For example,
when the outcome is binary, such as yes or no, a binomial or Bernoulli distribution
is assumed. When the outcome is count, a Poisson distribution is assumed. The
variance of the outcome can be written as a product of a single scale or dispersion
parameter, φ, and it is called the variance function:
V ar(Y ) = φv(µ). (27)
The systematic component of the generalized linear model identifies
explanatory variables. These explanatory variables are combined into a linear
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format, and it is called the linear predictor:
ηi = X
′
iβ = β1Xi1 + β2Xi2 + · · ·+ βpXip, (28)
where Xi1 = 1 for all i, and β1 is the intercept. β = (β1, . . . , βp)
′ is the vector of
unknown parameters (Fitzmaurice et al., 2004). The link function is a function that
connects the linear predictor with the mean of the probability distribution. So, the
function g(·) connects a random component to a systematic component, which can
be written as
g(ηi) = β1Xi1 + β2Xi2 + · · ·+ βpXip (29)
(Fitzmaurice et al., 2004). As an example, the variance and link function for the
Gaussian, Bernoulli, Poisson, and Gamma distributions are as follows (Fitzmaurice
et al., 2004).
Table 2
Variances and link functions
Distribution Variance Function Link Function Mean Function
Gaussian v(µ) = 1 Identity: µ = η µ = η
Bernoulli v(µ) = µ(1− µ) Logit: log(µ/1− µ) = η µ = exp(η)
1−exp(η)
Poisson v(µ) = µ Log: log(µ) = η µ = exp(η)
Gamma v(µ) = µ2 Log: log(µ) = η µ = exp(η)
All the distributions from the exponential family can be expressed as
f(y; θ, φ) = exp
(
yθ − b(θ)
a(φ)
+ c(y, φ)
)
, (30)
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where θ is a canonical parameter and φ is a scale or dispersion parameter
(Fitzmaurice et al., 2004). The commonly used distributions of the outcomes are
the Gaussian for normally distributed outcomes, the Bernoulli for binary outcomes,
the Poisson for count outcomes, and the Gamma distribution for survival time or
waiting time. The probability density function of the Gaussian distribution can be
rewritten in an exponential family form of
f(y;µ, σ2) = (2piσ2)−1/2exp
(
−(y − µ)
2
2σ2
)
= exp
(
−1
2
log(2piσ2)
)
exp
(
−(y − µ)
2
2σ2
)
= exp
(
−(y
2 − 2yµ+ µ2)
2σ2
− 1
2
log(2piσ2)
)
= exp
(
yµ− µ2/2
σ2
− 1
2
(
y2
σ2
+ log(2piσ2)
))
,
(31)
with a canonical parameter and a dispersion parameter of
θ = µ and a(φ) = σ2. (32)
The probability density function of the Bernoulli distribution can be rewritten as
f(y;µ) = µy(1− µ)1−y
= exp(ylog(µ) + (1− y)log(1− µ))
= exp
(
ylog
(
µ
1− µ
)
+ log(1− µ)
)
,
(33)
with a canonical parameter and a dispersion parameter of
θ = log
(
µ
1− µ
)
= logit(µ) and a(pi) = 1. (34)
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The probability density function of the Poisson distribution can be rewritten as
f(y;µ) =
e−µµy
y!
= exp(ylog(µ)− µ− log(y!)),
(35)
with a canonical parameter and a dispersion parameter of
θ = log(µ) and a(φ) = 1 (36)
(Fitzmaurice et al., 2004). Lastly, the probability density function of the Gamma
distribution can be rewritten as
f(y;λ, v) =
yv−1λve−yλ
Γ(v)
= exp(−yλ+ vlog(λ) + (v − 1)log(y)− log(Γ(v))
= exp
(
y(−λ/v)− log(λ)
1/v
+ (v − 1)log(y)− log(Γ(v)
) (37)
with a canonical parameter and a dispersion parameter of
θ = −λ
v
and a(φ) =
1
v
. (38)
Joint Model
In this section, three joint models are presented with different outcome
types as examples, but time is still assumed to follow an exponential distribution.
Examples of the outcome distributions include the Bernoulli for binary, the Poisson
for count, and the Gamma distribution for survival time or waiting time. Also, the
mean function and the link function for each distribution are modified to take
34
account of the dependency among the current outcome, one-step prior outcome,
and current time into the model.
Bernoulli-Exponential Model
This joint model is for binary outcomes and informative time. The
Bernoulli distribution, in an exponential family form, can be expressed to handle
repeated outcomes with given dependency
f(yij|yij−1, tij, X) = µyijij (1− µij)1−yij
= exp
(
yijlog
(
µij
1− µij
)
+ log(1− µij)
)
,
(39)
where µi = E(Yi) = P (Yi = 1). The parameter is
θij = log
(
µij
1− µij
)
= logit(µij). (40)
The link function becomes
log
(
µij
1− µij
)
= β0 + β1x1 + · · ·+ βkxk + γtij + ϕyij−1
= X
′
iβ + γtij + ϕyij−1.
(41)
Then, the mean function can be expressed as
µij =
exp(X
′
iβ + γtij + ϕyij−1)
1 + exp(X
′
iβ + γtij + ϕyij−1)
. (42)
Hence, the mean function for the initial value for the ith subject and the mean
function after the initial value can be expressed as
µi1 =
exp(X ′iβ)
1 + exp(X ′iβ)
and µij =
exp(X ′iβ + γtij + ϕyij−1)
1 + exp(X ′iβ + γtij + ϕyij−1)
. (43)
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Finally, the joint model for the Bernoulli-Exponential model can be written as
fΘ(yi, ti) = exp
(
yi1log
(
µi1
1−Ai1
)
+ log(1− µi1)
)
×
ni∏
j=2
{
exp
(
yij log
(
µij
1− µij
)
+ log(1− µij)
)
· exp(α+ δyij−1) · exp(−eα+δyij−1tij)
}
.
(44)
The likelihood function, which is the product of the density functions for m
individuals, is
L(Θ, yi, . . . , ym) =
m∏
i=1
{
exp
(
yi1log
(
µi1
1− µi1
)
+ log(1− µi1)
)
×
ni∏
j=2
exp
(
yijlog
(
µij
1− µij
)
+ log(1− µij)
)
· exp(α + δyij−1) · exp(−eα+δyij−1tij)
}
.
(45)
Generally, the log-likelihood function is used to find the parameter estimates for
convenience. The log-likelihood function for the ith individual in the model
becomes
li =log
{
exp
(
yi1log
(
µi1
1− µi1
)
+ log(1− µi1)
)
×
ni∏
j=2
exp
(
yijlog
(
µij
1− µij
)
+ log(1− µij)
)
· exp(α + δyij−1) · exp(−eα+δyij−1tij)
}
=
(
yi1log
(
µi1
1− µi1
)
+ log(1− µi1)
)
+
ni∑
j=2
{
(yijlog
(
µij
1− µij + log(1− µij
)
+ α + δyij−1 − eα+δyij−1tij)
}
.
(46)
The log-likelihood function for all individuals is the sum of m individuals’
log-likelihood functions, as shown below.
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l =
m∑
i=1
li =
m∑
i=1
(
yi1log
(
µi1
1− µi1
)
+ log(1− µi1)
)
+
m∑
i=1
ni∑
j=2
(
yijlog
(
µij
1− µij
)
+ log(1− µij)
)
+
m∑
i=1
ni∑
j=2
(α + δyij−1 − eα+δyij−1tij).
(47)
Poisson-Exponential Model
This joint model is for count outcomes and informative time with an
exponential distribution. Since the Poisson distribution is a member of the
exponential family, it can be rewritten as
f(yij|yij−1, tij, X) =
e−µijµyijij
yij!
= exp(yijlog(µij)− µij − log(yij!)).
(48)
The parameter is
θij = log(µij). (49)
The canonical link function becomes
log(µij) = β0 + β1x1 + · · ·+ βkxk + γtij + ϕyij−1
= X
′
iβ + γtij + ϕyij−1.
(50)
Then, the mean function is
µij = exp(X
′
iβ + γtij + ϕyij−1). (51)
Hence, the mean function for the initial value for the ith subject and the mean
function after the initial value can be expressed as
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µi1 = exp(X
′
iβ) and µij = exp(X
′
iβ + γtij + ϕyij−1). (52)
Then, the joint model of the Poisson-Expoential model becomes
fΘ(yi, ti) = exp(yi1log(µi1)− µi1 − log(yi1!))
×
ni∏
j=2
exp(yijlog(µij)− µij − log(yij!)) · exp(α + δyij−1) · exp(−eα+δyij−1tij).
(53)
The likelihood function for m individuals is
L(Θ, yi, . . . , ym) =
m∏
i=1
{
exp(yi1log(µi1)− µi1 − log(yi1!))
×
ni∏
j=2
exp(yijlog(µij)− µij − log(yij!)) · exp(α + δyij−1) · exp(−eα+δyij−1tij)
}
.
(54)
The log-likelihood function for the ith individual in the model becomes
li =log
{
exp(yi1log(µi1)− µi1 − log(yi1!))
×
ni∏
j=2
exp(yijlog(µij)− µij − log(yij!)) · exp(α + δyij−1) · exp(−eα+δyij−1tij)
}
=(yi1log(Ai1)− µi1 − log(yi1!))
+
ni∑
j=2
{
yijlog(µij)− µij − log(yij!)) + α + δyij−1 − eα+δyij−1tij
}
.
(55)
The log-likelihood function for all individuals, which is the sum of m individuals’
log-likelihood functions, is
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l =
m∑
i=1
li =
m∑
i=1
(yi1log(µi1)− µi1 − log(yi1!))
+
m∑
i=1
ni∑
j=2
(yijlog(µij)− µij − log(yij!))
+
m∑
i=1
ni∑
j=2
(α + δyij−1 − eα+δyij−1tij).
(56)
Gamma-Exponential Model
This joint model is used for waiting or survival time and informative time
with an exponential distribution. The density function of a random variable Y with
a Gamma distribution can be rewritten in an exponential family form:
f(yij|yij−1, tij, X) =
y
vij−1
ij λ
vij
ij e
−yijλij
Γ(vij)
= exp
(
yij(−1/µij)− log(µij)
1/vij
+ vijlog(vij) + (vij − 1)log(yij)− log(Γ(vij))
)
.
(57)
The θ becomes 1/µij, so the canonical link function and dispersion parameter are
g(µij) = − 1
µij
and a(φ) =
1
vij
. (58)
For the Gamma distribution, there are three link functions: (1) inverse link (g(µ) =
1/µ), (2) log link (g(µ) = log(µ)), and (3) identity link function (g(µ) = µ). The
log link function was used in this study. So, the mean function with the log link
function becomes
µij = exp(X
′
iβ + γtij + ϕyij−1). (59)
Hence, the mean function for the initial value for the ith subject and the mean
function after the initial value can be expressed as
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µi1 = exp(X
′
iβ) and µij = exp(X
′
iβ + γtij + ϕyij−1). (60)
As a consequence, the joint model for the Gamma distribution becomes
fΘ(yi, ti) = exp
(
yi1(−1/µi1)− log(µi1)
1/vij
+ vijlog(vij) + (vij − 1)log(yi1)− log(Γ(vij))
)
×
ni∏
j=2
(
exp
(
yij(−1/µij)− log(µij)
1/vij
+ vijlog(vij) + (vij − 1)log(yi1)− log(Γ(vij))
)
· exp(α + δyij−1) · exp(−eα+δyij−1tij)
)
.
(61)
The likelihood function is the product of the density functions for m individuals.
L(Θ, yi, . . . , ym) =
m∏
i=1
{
exp
(
yi1(−1/µi1)− log(µi1)
1/vij
+ vijlog(vij) + (vij − 1)log(yi1)− log(Γ(vij))
)
×
ni∏
j=2
exp
(
yij(−1/µij)− log(µij)
1/vij
+ vijlog(vij) + (vij − 1)log(yij)− log(Γ(vij))
)
· exp(α + δyij−1) · exp(−eα+δyij−1tij)
}
.
(62)
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The log-likelihood function for the ith individual in the model becomes
li =log
{
exp
(
yi1(−1/µi1)− log(µi1)
1/vij
+ vijlog(vij) + (vij − 1)log(yi1)− log(Γ(vij))
)
×
ni∏
j=2
(
exp
(
yij(−1/µij)− log(µij)
1/vij
+ vijlog(vij) + (vij − 1)log(yij)− log(Γ(vij))
)
· exp(α + δyij−1) · exp(−eα+δyij−1tij)
)}
=
(
yi1(−1/µi1)− log(µi1)
1/vij
+ vijlog(vij) + (vij − 1)log(yi1)− log(Γ(vij))
)
+
ni∑
j=2
(
yi1(−1/µij)− log(µij)
1/vij
+ vijlog(vij) + (vij − 1)log(yij)− log(Γ(vij))
+ α + δyij−1 − eα+δyij−1tij
)
.
(63)
Finally, the log-likelihood function for all individuals becomes
l =
m∑
i=1
li =
m∑
i=1
(
yi1(−1/µi1)− log(µi1)
1/vij
+ vijlog(vij) + (vij − 1)log(yi1)− log(Γ(vij))
)
+
m∑
i=1
ni∑
j=2
(
yij(−1/µij)− log(µij)
1/vij
+ vijlog(vij) + (vij − 1)log(yij)− log(Γ(vij))
)
+
m∑
i=1
ni∑
j=2
(
α + δyij−1 − eα+δyij−1tij
)
.
(64)
Parameter Estimation
The maximum likelihood estimators are defined as the values that maximize
the joint probability evaluated at their observed data (Fitzmaurice et al., 2004).
Generally, the log-likelihood function is used rather than the likelihood function for
joint probability because it is simpler to find the parameter estimates. However, as
can be seen, maximization of the log-likelihood function is not an easy job;
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therefore, mathematical iterative methods are needed. In the two previous studies,
the nonlinear optimization function called NLPDD in SAS/IML was used to find
the maximum likelihood estimators from the log-likelihood function. The NLPDD
function is a nonlinear optimization function using a double dogleg method, which
combines the quasi-Newton and trust-region methods. Many nonlinear optimization
methods are provided in SAS or R (Nash & Varadhan, 2011; SAS Institute, 2008).
None of them seems to be superior to any other methods in any situation. The
nonlinear optimization function, called maxLik in R, is chosen in the current study
since it provides a single, unified interface to various optimization routines, offering
easy access to likelihood-specific features. The Newton-Raphson maximization
algorithm is used by default in the maxLik function.
Parameter Testing
There are three ways of using the likelihood function: the Wald test, the
score test, and the likelihood ratio test. These are used for hypothesis testing, to
determine the significance of the parameter estimates, or to determine confidence
intervals (Agresti, 2007). The likelihood ratio test uses the ratio of two maximized
log-likelihood functions for two nested models: (1) the maximized log-likelihood
value for the null hypothesis denoted by lˆred; and (2) the maximized log-likelihood
value for the alternative hypothesis denoted by lˆfull. Hence, the likelihood ratio test
statistic is
2(lˆfull − lˆred) ∼ χ2dffull−dfred , (65)
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where dffull is the degrees of freedom for the full model and dfred is the degrees of
freedom for the reduced model. The ratio is compared to the chi-squared
distribution with the degrees of freedom equal to the difference between the two
models’ number of parameters. When the difference gets larger, it shows that the
reduced model is inappropriate (Fitzmaurice et al., 2004). This likelihood ratio test
is used to maintain the consistency from the previous study and ease of calculation.
Model Selection
Model selection criteria used in this study are the Akaike information
criterion (AIC), the Akaike information criterion with correction (AICc), and the
Bayesian information criterion (BIC) to compare non-nested models.
The AIC measures relative quality of a model to provide a method on
model selection with given data. The AIC is defined as
AIC = 2k − 2ln(L), (66)
where k is the number of parameters in the model and ln(L) is the maximized
value of the log-likelihood function of the model. The AIC takes into account both
the statistical goodness of fit and the number of parameters to be estimated. The
model with a low AIC value is preferred, which has the fewest number of
parameters with adequate fit to the data (Everitt, 2006).
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For example, since ln(L) is the maximized log-likelihood at Θˆ, the AIC for
the Bernoulli-Exponential model becomes
AIC = 2k − 2
{ m∑
i=1
yi1X
′
iβˆ + log
(
1
1 + exp(X
′
iβˆ)
)
+
m∑
i=1
ni∑
j=2
(
yij(X
′
iβˆ + γˆtij + ϕˆyij−1) + log
(
1
1 + exp(X
′
iβˆ + γˆtij + ϕˆyij−1)
))
+
m∑
i=1
ni∑
j=2
(
αˆ + δˆyij−1 − eαˆ+δˆyij−1tij
)}
.
(67)
The Poisson-Exponential model has the AIC of
AIC =2k − 2
{
m∑
i=1
(
yi1X
′
iβˆ − exp(X
′
iβˆ)− log(yij!)
)
+
m∑
i=1
ni∑
j=2
(
yij(X
′
iβˆ + γˆtij + ϕˆyij−1)− exp(X
′
iβˆ + γˆtij + ϕˆyij−1)− log(yij!)
)
+
m∑
i=1
ni∑
j=2
(
αˆ + δˆyij−1 − eαˆ+δˆyij−1tij
)}
.
(68)
The AIC of the Gamma-Exponential model becomes
AIC =2k − 2
{
m∑
i=1
(
yi1(−1/exp(X ′iβˆ))−X
′
iβˆ
1/vˆij
+ vˆij log(vˆij) + (vˆij − 1)log(yi1)− log(Γ(vˆij))
)
+
m∑
i=1
ni∑
j=2
(
yij(−1/exp(X ′iβˆ + γˆtij + ϕˆyij−1))− (X
′
iβˆ + γˆtij + ϕˆyij−1)
1/vˆij
+ vˆij log(vˆij) + (vˆij − 1)log(yi1)− log(Γ(vˆij))
)
+
m∑
i=1
ni∑
j=2
(
αˆ+ δˆyij−1 − eαˆ+δˆyij−1tij
)}
.
(69)
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The AICc is the AIC with a correction for finite sample sizes and is defined as
AICc = AIC +
2k(k + 1)
n− k − 1 , (70)
where k is the number of parameters and n is the sample size. The AIC performs
poorly with small sample sizes and AICc converges to AIC as n increases, so AICc
is recommended (Burnham & Anderson, 2002).
Bayesian information criterion (BIC) is given by
BIC = −2ln(L) + klog(n), (71)
where k is the number of parameters and n is the sample size. The penalty
associated with BIC is more severe than that of AIC because the sample size is
included in the function. Like AIC, a model with the lowest BIC value is preferred.
The use of BIC is not recommended due to a high risk of selecting a model that is
too simple or parsimonious (Fitzmaurice et al., 2004). However, in a simulation
study, the BIC outperformed the AIC as sample size increased (McQuarrie,
Shumway, & Tsai, 1997). Therefore, BIC is included since this study uses the
log-likelihood function in the process of finding parameter estimates.
Data Simulation
This study is an extension of the studies of Bronsert (2009) and Lin (2011).
To maintain consistency, all of the parameter values in Table 3 and simulation
conditions in Table 4 were adopted from Lin’s study. The joint model developed by
the two researchers can be used only when outcomes follow a normal distribution
and time follows an exponential distribution. Since the purpose of this study was to
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develop joint models for members of the exponential family of distributions for
outcomes with an exponential distribution for time, three outcome distributions
were used in this study as examples. These are the Bernoulli for binary outcomes,
the Poisson distribution for counts, and the Gamma distribution for waiting time or
survival time.
In the two previous studies, Monte Carlo simulations were utilized using
SAS/IML. Lin used the Henze-Zirkler multivariate normality test statistic
computed in the PROC MODEL procedure. During this study, a program error
was found in that procedure in the software. Consequently, a SAS problem note
was posted on their website (http://support.sas.com/kb/51/281.html) on October
11, 2013. The SAS company said that the Henze-Zirkler test should not be used to
test for multivariate normality. Therefore, this study retested the simulation results
of the previous study done by Lin, by using R instead of SAS.
The basic structure of simulated data has two categorical variables with
three levels each and two continuous variables. The values of the dependent
variables are generated from the Bernoulli, the Poisson, and the Gamma
distributions respectively. The first outcome is generated from each distribution,
then the next outcome is calculated based on the relationship between the previous
outcome and the previous time to predict the average outcome with fixed
parameter values in Table 3. All parameter values are assumed to be equal across
subjects for simplicity of model form in simulation studies. The scale parameter
values (v) in Table 3 are used for the Gamma distribution only.
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Table 3
Parameter Values for Simulations
v β0 β1 β2 β3 β4 β5 β6 ϕ γ α δ
1 0.4 0.2 0.3 0.1 0.3 0.4 0.9 0.8 0.1 2 0.01
1 0.4 0.2 0.3 0.1 0.3 0.4 0.9 0.8 0.1 1 0.02
1 0.4 0.2 0.3 0.1 0.3 0.4 0.9 0.8 0.1 2 0.01
1.2 0.4 0.2 0.3 0.1 0.3 0.4 0.9 0 0.1 1 0.02
1.2 0.4 0.2 0.3 0.1 0.3 0.4 0.9 0 0.1 2 0.01
1.2 0.4 0.2 0.3 0.1 0.3 0.4 0.9 0.8 0.1 1 0.02
To test multivariate normality of the estimators of the joint models, a
diversity of sample sizes and design structures (balanced or unbalanced) were
included in the simulations. As described in Table 4, five sample sizes are combined
with four types of design structures with a different number of observations.
Because sample sizes range from 18 to 180, simulation studies are believed to be
enough to see if the multivariate normality test shows a trend as sample size
increases. In addition, a different number of observations were included in each
sample size to check if there is a certain pattern as the number of observations
increases.
Some researchers used 1,000 replications (Lipsitz et al., 2002; Qiu et al.,
2013), and some used 500 replications (Liang et al., 2009). The number of
replications was 5,000 times in Lin’s study. In this study, each simulation design
was run 1,000 times. Each outcome distribution had 120 simulation designs.
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Therefore, the total number of simulation designs was 480 with the six parameter
schemes, five sample sizes, and four different numbers of observations with four
distributions.
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Table 4
Simulation Designs
Scheme Sample Number of Design Total number of
Number Size Observations Structure Observations
1 18 10 Balanced 180
2 5 & 3 Unbalanced 72
3 10 & 5 Unbalanced 135
4 20 & 6 Unbalanced 234
5 36 10 Balanced 360
6 5 & 3 Unbalanced 144
7 10 & 5 Unbalanced 180
8 20 & 6 Unbalanced 288
9 54 10 Balanced 540
10 5 & 3 Unbalanced 216
11 10 & 5 Unbalanced 405
12 20 & 6 Unbalanced 702
13 90 10 Balanced 900
14 5 & 3 Unbalanced 360
15 10 & 5 Unbalanced 675
16 20 & 6 Unbalanced 1170
17 180 10 Balanced 1800
18 5 & 3 Unbalanced 720
19 10 & 5 Unbalanced 1350
20 20 & 6 Unbalanced 2340
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As shown in Table 4, each sample size with a different number of
observations was simulated, and estimators were calculated. Those two procedures
were replicated 1,000 times, and multivariate normality was tested with 1,000 sets
of the estimators by using the Henze-Zirkler test. For example, when the sample
size is 54 and the number of observations is 5 & 3, 27 subjects have 5 outcomes
each and 27 subjects have 3 outcomes each, which makes the total number of
observations 216.
This study used the Henze-Zirkler multivariate normality test for checking
the property of the estimators of the joint models by using R instead of SAS due to
the error. The built-in function name is HZ.test in the MVN package. After
showing the test results, AIC, AICc, and BIC scores were calculated for model
selection purposes. Finally, the computing program package using R was applied to
a real dataset, bladder cancer data, and the output is presented.
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CHAPTER IV
RESULTS
Two main purposes of this study were (1) to build joint models with
longitudinal outcomes and informative time and verify if the asymptotic normality
of the maximum likelihood estimators holds for the joint models and (2) to
establish a computing program package that can handle the joint models by using
R. A partial result of the analysis of the bladder cancer data using the package is
presented at the end of this chapter to demonstrate the performance of the
package. To verify the asymptotic normality of the maximum likelihood estimators
of the joint models, four outcome distributions were selected as examples, and the
simulation results are presented in this chapter. The chosen outcome distributions
are the Gaussian, Bernoulli, Poisson, and Gamma distributions. The simulation
results of the Gaussian distribution are presented since an error was found in the
Henze-Zirkler multivariate normality test in SAS used by the previous researcher.
A general description of the simulation procedures is as follows. Firstly, a
design matrix is generated with two continuous and two categorical variables with
three levels each. Secondly, a dataset is created based on the fixed parameter values
shown in Table 3, in addition to the relations among previous and current outcomes
and previous time. Thirdly, the maximum likelihood estimators are computed using
a nonlinear parameter optimization function called maxLik in R. Fourthly, the
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parameter estimates are standardized by the standard error from the Hessian
matrix. The above four steps are repeated 1,000 times. The Henze-Zirkler test is
then used to test the multivariate normality of the 10,000 sets of parameter
estimates. The test was conducted separately for the parameter estimates of the
outcome and time processes. Simulation designs are based on five sample sizes, four
different observations, and six parameter schemes. Each outcome distribution has
120 (5 * 4 * 6) simulation conditions, which makes 480 simulation designs in total
for all four outcome distributions.
While simulating data, the logit link function for the Bernoulli, log link
function for the Poisson and Gamma distributions, and identity link function for
the Gaussian are used. The mean function of the Bernoulli becomes µ = exp(η)
1−exp(η) ,
and the mean function of the Poisson and Gamma is µ = exp(η). In addition, to
generate time points, another exponential function is used. Due to the two
exponential functions, oftentimes outcomes and time points quickly became
impractical. To avoid generating unrealistic outcomes and time points, the
parameter values in Table 3 on page 46 were multiplied by 1/10 to reduce the
magnitude.
For example, when X ′iB = 3 for the ith subject, µi = exp(X
′
iB) becomes
20.08. This value is passed to the second exponential function to generate a time
point, which is exp(20.08) = 528, 491, 311 without including any other terms in the
computation. Moreover, this value is plugged into a function to generate a random
number from the Poisson distribution. As a result, an outcome of 528,538,500 is
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generated, which is very unlikely to have in practice. This problem was resolved by
reducing the magnitude of the parameter values.
The computing package using R presented in Appendix D was designed to
handle outcome distributions, such as the Gaussian, Bernoulli, Poisson, and
Gamma, with informative time, which follows an exponential distribution. The
package uses the identity link function for the Gaussian, logit link function for the
Bernoulli, and log link function for the Poisson and Gamma distributions, by
default. But for the Gamma distribution, the inverse and identity link functions
can be used as well, in addition to the log link function. Once all the information
needed to utilize the package is provided, the package computes the estimators,
AIC, AICc, BIC, and likelihood ratio test statistic with a corresponding p-value for
a model. For demonstration purposes, the package was applied to the bladder
cancer data; then, the outputs generated by the package are shown in Appendix A
and B.
Simulation Results
The results of the multivariate normality tests for all simulation conditions
from the four selected outcome distributions are presented.
Gaussian-Exponential Model
As can be seen in Figure 1 and 4 and Table 5, multivariate normality is not
stable when the sample size is 18 for the outcome process. However, as sample size
increases, most of the cases show multivariate normality. In these figures, filled
circles represent the unbalanced simulation design, and unfilled circles are for the
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balanced simulation design. Figure 2 and 4 show the multivariate normality test
results at the significance level of α = 0.05 for each parameter scheme. When a
p-value of the test is less than 0.05, it is categorized into “Non-normal,” but
otherwise it is “Normal.” By looking at the plots, the effects of the design
structures are not clear. The Gaussian-Exponential model has ten parameters for
the outcome process and two for the time process.
For the time process, the multivariate normality test results can be seen in
Figure 5 and 8 and Table 6. Most of the test results show multivariate normality
even with the sample size of 18. Also, the design structures do not seem to affect
the multivariate normality of the estimators. The estimators of the time process
show a pattern in achieving normality slightly faster than the outcome process.
The previous researcher stated that “there was a tendency of achieving
multivariate normality as the number of subjects exceeds 54” for the outcome and
time processes (Lin, 2011, p. 60 & 65). However, in this study, most of the
simulation results for the Gaussian model obtained normality as sample size is
greater than 18 for both the outcome and time processes. It is assumed that the
Henze-Zirkler multivariate normality test in the PROC MODEL procedure in SAS
used by the previous researcher did not compute the test statistic correctly due to
the error in the software.
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Figure 1. Outcome Process of the Gaussian-Exponential Model (Subjects)
Figure 2. Outcome Process of the Gaussian-Exponential Model (Subjects)
55
Figure 3. Outcome Process of the Gaussian-Exponential Model (Observations)
Figure 4. Outcome Process of the Gaussian-Exponential Model (Observations)
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Table 5
Outcome Process of the Gaussian-Exponential Model: p-values of the Multivariate
Normality Test for different parameter schemes and sample sizes
Parameter Scheme
Sample Sample # of 1 2 3 4 5 6
Scheme Size Obs p-value p-value p-value p-value p-value p-value
1 18 180 0.29971 0.03930 0.00001 0.01529 0.53645 0.17374
2 72 0.00001 0.00001 0.00001 0.00001 0.00001 0.00001
3 135 0.01769 0.14771 0.00001 0.09001 0.22121 0.02722
4 234 0.15295 0.01213 0.00001 0.09044 0.61176 0.19633
5 36 360 0.32246 0.10253 0.00001 0.07367 0.12644 0.27061
6 144 0.34162 0.36361 0.24073 0.31887 0.20862 0.51200
7 180 0.37339 0.09288 0.89520 0.43668 0.18142 0.72612
8 288 0.11841 0.20394 0.78541 0.15052 0.94910 0.18182
9 54 540 0.51538 0.93902 0.01182 0.28265 0.60469 0.74613
10 216 0.36149 0.51311 0.45283 0.39490 0.15466 0.91270
11 405 0.65701 0.84358 0.53248 0.78497 0.61603 0.89729
12 702 0.33136 0.89321 0.79814 0.50627 0.66203 0.93771
13 90 900 0.20652 0.45802 0.40458 0.96591 0.17377 0.71388
14 360 0.29366 0.75052 0.35323 0.84260 0.54679 0.89042
15 675 0.41352 0.74227 0.69382 0.14320 0.36336 0.86635
16 1170 0.63985 0.06333 0.67474 0.57609 0.23243 0.68908
17 180 1800 0.06868 0.37988 0.53598 0.61698 0.46444 0.82726
18 720 0.24276 0.80939 0.76237 0.24585 0.83869 0.55219
19 1350 0.41318 0.32841 0.91741 0.68461 0.51855 0.47480
20 2340 0.58655 0.23763 0.78124 0.99267 0.69329 0.98776
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Figure 5. Time Process of the Gaussian-Exponential Model (Subjects)
Figure 6. Time Process of the Gaussian-Exponential Model (Subjects)
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Figure 7. Time Process of the Gaussian-Exponential Model (Observations)
Figure 8. Time Process of the Gaussian-Exponential Model (Observations)
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Table 6
Time Process of the Gaussian-Exponential Model: p-values of the Multivariate
Normality Test for different parameter schemes and sample sizes
Parameter Scheme
Sample Sample # of 1 2 3 4 5 6
Scheme Size Obs p-value p-value p-value p-value p-value p-value
1 18 180 0.00536 0.62492 0.44094 0.27630 0.06168 0.86184
2 72 0.09875 0.39235 0.26561 0.29329 0.23040 0.01546
3 135 0.79393 0.43889 0.61088 0.22100 0.40391 0.80296
4 234 0.96929 0.06662 0.29046 0.25676 0.11720 0.55487
5 36 360 0.37019 0.59933 0.38449 0.19781 0.05106 0.65543
6 144 0.09881 0.08263 0.04383 0.64623 0.08940 0.27226
7 180 0.61501 0.65657 0.51750 0.96478 0.07434 0.63833
8 288 0.42738 0.01507 0.32936 0.01262 0.85221 0.36209
9 54 540 0.77590 0.94485 0.70976 0.10574 0.53873 0.22542
10 216 0.25769 0.62343 0.52139 0.36188 0.80927 0.22598
11 405 0.52672 0.41992 0.23673 0.41124 0.62807 0.83770
12 702 0.39817 0.19285 0.45714 0.20934 0.56195 0.65525
13 90 900 0.82082 0.51221 0.10389 0.95954 0.71905 0.97961
14 360 0.37800 0.33752 0.23034 0.88490 0.70013 0.49251
15 675 0.59168 0.11903 0.63875 0.34989 0.77778 0.22766
16 1170 0.90701 0.47944 0.65285 0.09478 0.70765 0.42658
17 180 1800 0.35810 0.95003 0.20777 0.29659 0.81707 0.13618
18 720 0.25920 0.75638 0.38214 0.86188 0.42393 0.86280
19 1350 0.24551 0.70440 0.27935 0.77896 0.26871 0.46085
20 2340 0.78797 0.57098 0.44826 0.43375 0.66599 0.93396
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Bernoulli-Exponential Model
The simulation results of the multivariate normality tests for the outcome
process are shown in Figure 9 and 12 and Table 7. As can be seen, some simulation
designs do not obtain multivariate normality when the sample size is 18. However,
when sample size goes beyond 18, it has a tendency of obtaining multivariate
normality in most of the cases. The test results for the time process are shown in
Figure 13 and 16 and Table 8. Like the Gaussian and Poisson models, design
structures do not seem to affect the test results. Compared to the Gaussian model,
the Bernoulli model is slightly slower to obtain multivariate normality in both
outcome and time processes. The Bernoulli model shows, however, the same
pattern for obtaining multivariate normality as sample size increases.
Figure 9. Outcome Process of the Bernoulli-Exponential Model (Subjects)
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Figure 10. Outcome Process of the Bernoulli-Exponential Model (Subjects)
Figure 11. Outcome Process of the Bernoulli-Exponential Model (Observations)
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Figure 12. Outcome Process of the Bernoulli-Exponential Model (Observations)
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Table 7
Outcome Process of the Bernoulli-Exponential Model: p-values of the Multivariate
Normality Test for different parameter schemes and sample sizes
Parameter Scheme
Sample Sample # of 1 2 3 4 5 6
Scheme Size Obs p-value p-value p-value p-value p-value p-value
1 18 180 0.05675 0.08736 0.55261 0.40705 0.02049 0.02893
2 72 0.00170 0.00001 0.00443 0.00005 0.00001 0.00001
3 135 0.08779 0.07709 0.36283 0.00722 0.75259 0.44204
4 234 0.23295 0.80118 0.01941 0.44327 0.11254 0.02502
5 36 360 0.75219 0.03635 0.10186 0.51965 0.69102 0.57244
6 144 0.03161 0.23727 0.05807 0.30133 0.03666 0.55714
7 180 0.17731 0.08543 0.00142 0.55424 0.10476 0.00169
8 288 0.79914 0.22383 0.81402 0.02987 0.74556 0.12857
9 54 540 0.92032 0.01005 0.67330 0.08488 0.28485 0.38808
10 216 0.30015 0.16119 0.04276 0.63300 0.93464 0.21757
11 405 0.44539 0.26563 0.01529 0.01394 0.12901 0.23853
12 702 0.33028 0.76880 0.05700 0.53018 0.42188 0.33184
13 90 900 0.15870 0.14108 0.12986 0.88998 0.10659 0.65001
14 360 0.48833 0.58988 0.55276 0.07854 0.12428 0.73702
15 675 0.12926 0.31151 0.05007 0.72414 0.03409 0.49010
16 1170 0.89959 0.59373 0.72635 0.80065 0.56804 0.53755
17 180 1800 0.18810 0.91157 0.57165 0.72655 0.94775 0.35183
18 720 0.07356 0.16238 0.78948 0.49637 0.87328 0.65930
19 1350 0.17788 0.24911 0.25517 0.64486 0.16041 0.13796
20 2340 0.23908 0.57153 0.28496 0.28281 0.13885 0.15042
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Figure 13. Time Process of the Bernoulli-Exponential Model (Subjects)
Figure 14. Time Process of the Bernoulli-Exponential Model (Subjects)
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Figure 15. Time Process of the Bernoulli-Exponential Model (Observations)
Figure 16. Time Process of the Bernoulli-Exponential Model (Observations)
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Table 8
Time Process of the Bernoulli-Exponential Model: p-values of the Multivariate
Normality Test for different parameter schemes and sample sizes
Parameter Scheme
Sample Sample # of 1 2 3 4 5 6
Scheme Size Obs p-value p-value p-value p-value p-value p-value
1 18 180 0.63656 0.25638 0.83782 0.88686 0.80580 0.39971
2 72 0.02153 0.01852 0.09288 0.74398 0.14944 0.20743
3 135 0.11022 0.15489 0.08093 0.13597 0.56070 0.46692
4 234 0.21111 0.84092 0.54910 0.79137 0.54731 0.94560
5 36 360 0.23178 0.14502 0.60016 0.28552 0.65038 0.27444
6 144 0.82361 0.59250 0.49520 0.00784 0.35823 0.05031
7 180 0.51769 0.20966 0.16625 0.24893 0.27654 0.60556
8 288 0.48287 0.07160 0.79540 0.00947 0.77695 0.07273
9 54 540 0.65554 0.77282 0.66345 0.81803 0.09565 0.49507
10 216 0.23119 0.04746 0.16934 0.10530 0.33313 0.17070
11 405 0.04573 0.57223 0.53258 0.63360 0.52933 0.72817
12 702 0.85915 0.44562 0.57071 0.01737 0.84832 0.25854
13 90 900 0.35063 0.58724 0.38891 0.75017 0.99741 0.79655
14 360 0.82732 0.22178 0.37066 0.77456 0.18029 0.30316
15 675 0.87315 0.20865 0.85218 0.72115 0.38335 0.62810
16 1170 0.13283 0.91835 0.68403 0.05189 0.61365 0.77964
17 180 1800 0.60475 0.27057 0.91102 0.11225 0.40229 0.48817
18 720 0.52796 0.20331 0.86455 0.42649 0.34244 0.05321
19 1350 0.38633 0.95209 0.05218 0.74395 0.61988 0.34718
20 2340 0.55747 0.35095 0.18420 0.92866 0.66420 0.17732
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Poisson-Exponential Model
The results of the multivariate normality tests for the outome process are
shown in Figure 17 and 20 and Table 9. Figure 21 and 24 and Table 10 are
presented for the time process. When the sample size is 18, some of the p-values
are smaller than 0.05. But when sample size goes over 18, most cases obtain
normality in the outcome and time processes. The effects of design structures are
not clear. The outcome and time process of the Poisson model show a similar
pattern to the Bernoulli model in obtaining multivariate normality.
Figure 17. Outcome Process of the Poisson-Exponential Model (Subjects)
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Figure 18. Outcome Process of the Poisson-Exponential Model (Subjects)
Figure 19. Outcome Process of the Poisson-Exponential Model (Observations)
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Figure 20. Outcome Process of the Poisson-Exponential Model (Observations)
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Table 9
Outcome Process of the Poisson-Exponential Model: p-values of the Multivariate
Normality Test for different parameter schemes and sample sizes
Parameter Scheme
Sample Sample # of 1 2 3 4 5 6
Scheme Size Obs p-value p-value p-value p-value p-value p-value
1 18 180 0.10057 0.02895 0.18157 0.00001 0.16507 0.00514
2 72 0.00021 0.00001 0.22112 0.00001 0.02607 0.00001
3 135 0.36130 0.00001 0.16868 0.00001 0.07339 0.00001
4 234 0.67790 0.00163 0.00080 0.01920 0.44829 0.00001
5 36 360 0.08865 0.38247 0.64722 0.04076 0.27216 0.00293
6 144 0.11726 0.00986 0.00362 0.09490 0.05695 0.00001
7 180 0.15288 0.02433 0.23448 0.00053 0.23166 0.00086
8 288 0.28679 0.26373 0.09063 0.26016 0.23803 0.05345
9 54 540 0.31881 0.00039 0.01431 0.06875 0.51118 0.02247
10 216 0.41920 0.01423 0.21104 0.05748 0.39067 0.06158
11 405 0.44330 0.15155 0.82205 0.06632 0.22130 0.09995
12 702 0.28225 0.41316 0.47929 0.01236 0.16226 0.16811
13 90 900 0.27823 0.11821 0.11337 0.37641 0.45065 0.24115
14 360 0.28681 0.18526 0.12320 0.27628 0.53792 0.27771
15 675 0.23369 0.52214 0.07221 0.27438 0.18044 0.77676
16 1170 0.45542 0.61720 0.74317 0.88513 0.61144 0.42771
17 180 1800 0.56882 0.41468 0.49275 0.72791 0.62766 0.56920
18 720 0.20004 0.68145 0.42954 0.30436 0.31401 0.42366
19 1350 0.60901 0.10406 0.21374 0.52314 0.43834 0.25464
20 2340 0.90283 0.18755 0.19736 0.86215 0.52802 0.42036
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Figure 21. Time Process of the Poisson-Exponential Model (Subjects)
Figure 22. Time Process of the Poisson-Exponential Model (Subjects)
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Figure 23. Time Process of the Poisson-Exponential Model (Observations)
Figure 24. Time Process of the Poisson-Exponential Model (Observations)
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Table 10
Time Process of the Poisson-Exponential Model: p-values of the Multivariate
Normality Test for different parameter schemes and sample sizes
Parameter Scheme
Sample Sample # of 1 2 3 4 5 6
Scheme Size Obs p-value p-value p-value p-value p-value p-value
1 18 180 0.36968 0.05920 0.56300 0.00001 0.17918 0.04218
2 72 0.11893 0.44316 0.00997 0.26382 0.36458 0.00143
3 135 0.69557 0.47282 0.80654 0.31771 0.77710 0.70368
4 234 0.11195 0.33696 0.52556 0.11119 0.06275 0.55649
5 36 360 0.63561 0.51381 0.03773 0.00701 0.94172 0.59264
6 144 0.76581 0.12487 0.86573 0.03754 0.43839 0.36994
7 180 0.59204 0.21128 0.78980 0.18652 0.08187 0.86942
8 288 0.99272 0.39981 0.84805 0.60154 0.66689 0.85443
9 54 540 0.59380 0.84378 0.98316 0.93627 0.87752 0.92402
10 216 0.11246 0.16843 0.69691 0.38750 0.27582 0.17288
11 405 0.74750 0.55241 0.49931 0.10998 0.39248 0.85567
12 702 0.57741 0.07716 0.17194 0.94672 0.86231 0.62319
13 90 900 0.43914 0.09881 0.60773 0.41156 0.21464 0.31899
14 360 0.21623 0.88285 0.12009 0.72366 0.71011 0.25202
15 675 0.28960 0.52017 0.06290 0.17220 0.84827 0.12679
16 1170 0.72832 0.62466 0.52392 0.32749 0.66726 0.83152
17 180 1800 0.21276 0.32669 0.77498 0.46644 0.44065 0.74302
18 720 0.57254 0.12714 0.84636 0.75986 0.15928 0.41047
19 1350 0.10377 0.82882 0.68000 0.70381 0.58446 0.32260
20 2340 0.47510 0.11559 0.30508 0.27282 0.40995 0.86716
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Gamma-Exponential Model
The test results of the multivariate normality tests for the outcome process
are shown in Figure 25 and 28 and Table 11. The test results for the time process
are presented in Figure 29 and 32 and Table 12. Compared to other models, the
parameter estimates of the Gamma-Exponential model obtain normality a little
slowler, but the estimators of the model still show the same pattern.
Figure 25. Outcome Process of the Gamma-Exponential Model (Subjects)
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Figure 26. Outcome Process of the Gamma-Exponential Model (Subjects)
Figure 27. Outcome Process of the Gamma-Exponential Model (Observations)
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Figure 28. Outcome Process of the Gamma-Exponential Model (Observations)
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Table 11
Outcome Process of the Gamma-Exponential Model: p-values of the Multivariate
Normality Test for different parameter schemes and sample sizes
Parameter Scheme
Sample Sample # of 1 2 3 4 5 6
Scheme Size Obs p-value p-value p-value p-value p-value p-value
1 18 180 0.01510 0.17792 0.00003 0.08083 0.00001 0.00262
2 72 0.00001 0.00001 0.01978 0.00031 0.00001 0.00001
3 135 0.00210 0.00001 0.01978 0.03275 0.00001 0.00001
4 234 0.00103 0.00128 0.02076 0.34407 0.11764 0.00001
5 36 360 0.35421 0.00001 0.01028 0.06356 0.40382 0.00825
6 144 0.00722 0.00019 0.00001 0.32497 0.22074 0.00046
7 180 0.08193 0.02348 0.01526 0.02878 0.22582 0.05744
8 288 0.23467 0.02400 0.05475 0.50811 0.09404 0.29712
9 54 540 0.49101 0.75876 0.05001 0.06823 0.00321 0.40774
10 216 0.21903 0.04334 0.34122 0.23272 0.01000 0.31520
11 405 0.05726 0.38631 0.13727 0.38797 0.66817 0.28811
12 702 0.33324 0.12490 0.81706 0.10886 0.14504 0.10684
13 90 900 0.96265 0.32650 0.23116 0.78075 0.31541 0.30844
14 360 0.00042 0.84341 0.02709 0.05386 0.52406 0.06959
15 675 0.28685 0.22844 0.30391 0.61856 0.74784 0.48915
16 1170 0.49667 0.99965 0.22644 0.38226 0.51399 0.12637
17 180 1800 0.11085 0.17630 0.98062 0.28320 0.10254 0.32523
18 720 0.12046 0.23472 0.13587 0.28952 0.27900 0.71762
19 1350 0.77981 0.47663 0.07182 0.52340 0.63300 0.11060
20 2340 0.97624 0.05044 0.89781 0.79816 0.97604 0.43067
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Figure 29. Time Process of the Gamma-Exponential Model (Subjects)
Figure 30. Time Process of the Gamma-Exponential Model (Subjects)
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Figure 31. Time Process of the Gamma-Exponential Model (Observations)
Figure 32. Time Process of the Gamma-Exponential Model (Observations)
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Table 12
Time Process of the Gamma-Exponential Model: p-values of the Multivariate
Normality Test for different parameter schemes and sample sizes
Parameter Scheme
Sample Sample # of 1 2 3 4 5 6
Scheme Size Obs p-value p-value p-value p-value p-value p-value
1 18 180 0.86572 0.37131 0.00100 0.67151 0.60584 0.27504
2 72 0.29841 0.00741 0.08825 0.27548 0.09334 0.09979
3 135 0.77992 0.16504 0.08825 0.72134 0.32923 0.01447
4 234 0.35246 0.64602 0.00409 0.48813 0.11194 0.09114
5 36 360 0.07756 0.49069 0.54544 0.74836 0.19391 0.03679
6 144 0.22799 0.40778 0.11894 0.12180 0.98087 0.14305
7 180 0.63773 0.67727 0.00129 0.85998 0.06022 0.17012
8 288 0.15240 0.04646 0.00432 0.18650 0.54985 0.77054
9 54 540 0.71251 0.67581 0.29709 0.33731 0.41851 0.94068
10 216 0.74534 0.85472 0.05161 0.23272 0.01336 0.89112
11 405 0.63544 0.88261 0.25709 0.28075 0.12749 0.13077
12 702 0.73240 0.81992 0.31355 0.02845 0.44592 0.79969
13 90 900 0.74591 0.26546 0.40587 0.31457 0.03915 0.80940
14 360 0.19773 0.68945 0.60848 0.29627 0.41734 0.49496
15 675 0.22578 0.20036 0.85129 0.79418 0.34258 0.50440
16 1170 0.01130 0.02301 0.69937 0.96062 0.06400 0.31042
17 180 1800 0.53021 0.47935 0.61597 0.11075 0.16306 0.57966
18 720 0.55779 0.74150 0.65422 0.04132 0.87813 0.47186
19 1350 0.81460 0.61568 0.14774 0.23289 0.06044 0.36606
20 2340 0.76442 0.15216 0.68042 0.49321 0.58991 0.73169
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Overall, the design structures, balanced or unbalanced, do not seem to
affect multivariate normality. And the maximum likelihood estimators of the
outcome and time processes of the joint models gain asymptotic multivariate
normality as sample size goes beyond 18. Also, p-values of the tests have an
increasing trend as sample size increases. In addition, the estimators of the time
process obtain asymptotic multivariate normality faster than the outcome process.
Likelihood Ratio Test
For Research Question Three, the simulation study shows that the
parameter estimates of the joint models have the asymptotic normal distribution;
therefore, the likelihood ratio test statistic can be computed and used for
comparing nested models. The likelihood ratio test assumes that the asymptotic
normality of the parameter estimates is satisfied.
The likelihood ratio test statistic is twice the difference in the two nested
models’ maximized log-likelihoods; thus, it can be written as
2(lˆfull − lˆred) ∼ χ2dffull−dfred .
The test statistic is compared to a chi-squared distribution. The common likelihood
ratio test is for testing if all parameter estimates but the intercept (β0) are zero,
H0 :

β
γ
ϕ
 = 0.
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For instance, the maximized log-likelihood of the full model of the
Bernoulli-Exponential model is
lˆfull =
m∑
i=1
(
yi1log
(
µi1
1− µi1
)
+ log(1− µi1)
)
+
m∑
i=1
ni∑
j=2
(
yij log
(
µij
1− µij
)
+ log(1− µij)
)
,
(72)
where
µi1 =
exp(X ′iβˆ)
1 + exp(X ′iβˆ)
and µij =
exp(X ′iβˆ + γˆtij + ϕˆyij−1)
1 + exp(X ′iβˆ + γˆtij + ϕˆyij−1)
. (73)
The maximized log-likelihood of the reduced model of the Bernoulli-Exponential
model is
lˆred =
m∑
i=1
(
yi1log
(
µi1
1− µi1
)
+ log(1− µi1)
)
+
m∑
i=1
ni∑
j=2
(
yij log
(
µij
1− µij
)
+ log(1− µij)
)
,
(74)
where
µi1 =
exp(X ′i · 0)
1 + exp(X ′i · 0)
and µij =
exp(X ′i · 0 + 0 · tij + 0 · yij−1)
1 + exp(X ′i · 0 + 0 · tij + 0 · yij−1)
. (75)
Thus, the likelihood ratio test statistic can be calculated by taking the difference
between the two maximized log-likelihoods of the two models multiplied by two.
This concept is applied to the other joint models.
Information Criteria
For Research Question Four, the AIC, AICc, and BIC are computed as
model selection criteria. The AIC is expressed as 2k − 2lˆ, where lˆ is the maximized
log-likelihood evaluated at θˆ. The log-likelihood functions for different outcome
distributions studied were described in Chapter III. The AICc has the form of
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AIC + 2k(k−1)
n−k−1 and the BIC is −2lˆ + klog(n), which both are the extention of the
AIC. The computing program package calculates those model selection criteria,
along with the likelihood ratio test statistic.
Analysis of Bladder Cancer Data
The proposed joint models were applied to the bladder cancer data
provided in R, and the outputs generated by the computing package are presented
in this section and Appendix A and B. R provides two different datasets, bladder
and bladder1 in the package called survival. The bladder1 is the full dataset with
118 subjects, and the bladder is the subset of the bladder1 with 85 subjects and a
reduced number of variables. The bladder cancer dataset has been studied by many
methodologists, Cai, Lu, and Zhang (2012), Sun and Wei (2000), Sun, Park, Sun,
and Zhao (2005), and Zhang (2002). The bladder dataset is most commonly used
by many researchers for recurrent event modeling (R Core Team, 2014). To
demonstrate the performance of the computing package, the Bernoulli-Exponential
model was applied to the bladder dataset, and the Poisson-Exponential model was
applied to the bladder1 dataset. The variable “stop” in both datasets measure the
time interval (in months) since the last visit. Moreover, the next visiting time is
scheduled depending on the recurrence of bladder tumor at the time of
measurement. Therefore, time becomes informative, and time intervals become
irregular across all subjects. The variable “rx” in the bladder or “treatment” in the
bladder1 represents treatment types, such as placebo, pyridoxine, and thiotepa.
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Two treatment types are included in the bladder, and three treatments in the
bladder1.
Bernoulli-Exponential Model
The bladder cancer dataset is composed of 85 subjects with bladder tumors
who were assigned to either thiotepa or placebo treatment group. For each patient,
the recurrence of tumors, treatment, initial number of tumors, size (cm) of the
largest initial tumor, and visiting time (in months) since the last visit were
recorded. The status variable “event” for the recurrence of tumors has 1 for
recurrence and 0 for everything else (including death for any reason). Therefore,
the Bernoulli-Exponential model was applied with the “event” as an outcome
variable. The chosen research interest is to study the effects of the treatment,
initial number of tumors, and size of the largest initial tumor on tumor recurrence.
In the bladder dataset, all patients were measured four times.
The placebo treatment group has 47 randomly selected patients, and the
thiotepa group has 38 patients. The likelihood ratio test statistic and the
corresponding p-value for each model shown in Table 13 can be used to test if all βs
but β0 equal to zero. Based on the information criteria, AIC, AICc, and BIC, the
best fitting model is the one with the treatment, prior outcome, and current time
as predictors. Based on the output in the Appendex A says that the treatment (=
rx) has a non-significant effect on cancer recurrence (β1 = 0.2480 with p-value of
0.248). However, the prior outcome has a significant effect (ϕ = 4.3312 with p-value
of < .0001), and the current time has a significant effect (γ = −0.1412 with p-value
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of < .0001) as well. More descriptions of the data and the output for each model
are provided in Appendix A.
Table 13
Model Selection Criteria for the Bernoulli-Exponential Model
Model AIC AICc BIC LR Test P-value
event ∼ rx+ number + size 2652.85 2654.74 2692.39 199.10 < 0.0001
event ∼ rx+ number 2651.44 2652.90 2668.54 198.51 < 0.0001
event ∼ rx+ size 2651.64 2653.09 2668.73 198.31 < 0.0001
event ∼ rx 2650.60 2651.67 2665.25 197.35 < 0.0001
Poisson-Exponential Model
The bladder1 dataset is the full data set of the study for 118 patients, and
the maximum observed number of recurrences is 9. The dataset contains all three
treatments, placebo, pyridoxine, and thiotepa, with a variable “rtumor”, the
number of tumors found at the time of recurrence. The Poisson-Exponential model
was then applied to model the number of tumors with predictors, such as the
treatments, initial number of tumors, and size of the largest initial tumor. The
same predictors used in the Bernoulli-Exponential model were used with the
variable “rtumor” as an outcome variable. Based on the information criteria
presented in Table 14, the model with the treatment, prior outcome, and current
time as predictors is selected as the best fitting model. In the model, the
“thiotepa” in the treatment and the prior outcome have significant effects on the
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number of tumors (β2 = −0.274 and ϕ = 0.078 with p-value of 0.023 and < .0001,
respectively). Also, the likelihood ratio test statistic and the corresponding p-value
for each model are presented in Table 14. More information about the data and the
output for each model are presented in Appendix B.
Table 14
Model Selection Criteria for the Poisson-Exponential Model
Model AIC AICc BIC LR Test P-value
rtumor ∼ trt+ number + size 2220.32 2223.78 2239.47 45.50 < 0.0001
rtumor ∼ trt+ number 2219.59 2222.31 2236.61 44.23 < 0.0001
rtumor ∼ trt+ size 2218.47 2221.19 2235.49 45.35 < 0.0001
rtumor ∼ trt 2218.13 2220.21 2233.02 43.69 < 0.0001
The term “trt” in the above table is a shortened word for treatment. The
second model, “rtumor ∼ treatment + number,” in the table above, was studied by
Cai et al. (2012). Their research interest was to study the effects of the treatment
and number of initial tumors on tumor recurrence. The difference is that those
researchers studied a time-varying latent effect model with time-independent
covariates. The model they found is shown below.
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Table 15
Coefficients of the Latent Effect Model
Est. SE
Treatment -0.152 0.042
Number of initial tumors 0.205 0.050
For model comparisons, the coefficients of the Poisson-Exponential model
are provided below.
Table 16
Coefficients of the Poisson-Exponential Model
Coefficient Estimate Std. error t value Pr(> |t|)
Intercept 0.9328 0.0758 12.3010 < .0001
treatment.pyridoxine -0.0100 0.1015 -0.0993 0.9208
treatment.thiotepa -0.3001 0.1266 -2.3709 0.0177
number 0.0160 0.0218 0.7364 0.4614
Prior Outcome 0.0784 0.0183 4.2848 < .0001
Current Time 0.0006 0.0030 0.2032 0.8389
Even though these two models have different concepts, both models found that the
treatment has a negative effect on the number of tumors. The output above shows
that the third treatment level, thiotepa, has a significant negative effect on the
number of tumors (β2 = −0.3001 with p-value of 0.0177), and that the number of
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initial tumors is not significant on the tumor occurrence (β3 = 0.0160 with p-value
of 0.4614).
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CHAPTER V
CONCLUSION AND DISCUSSIONS
Conclusion
The purpose of this study was to test if the Gaussian-Exponential model
(Bronsert, 2009; Lin, 2011) can be extended to outcomes belonging to the
exponential family of distributions. The simulation studies were conducted with six
parameter schemes, two design structures, and five sample sizes, to test the
asymptotic multivariate normality of the maximum likelihood estimators of the
extended joint models. Outcome distributions considered in this study were the
Gaussian, Bernoulli, Poisson, and Gamma distributions. In all of the simulation
designs, the maximum likelihood parameter estimates of the joint models appeared
to be multivariate normal as the number of observations increased. As a result, the
likelihood ratio test statistic could be utilized for model comparisons since the
asymptotic normality of the maximum likelihood estimators has been verified. Also,
AIC, AICc, and BIC scores were calculated as model selection criteria.
Furthermore, the computing package using R was developed to handle the joint
models and used to analyze the bladder cancer data for demonstration purposes.
Also, a part of this study was to retest the simulation results for the
Gaussian-Exponential model, since an error was found in the Henze-Zirkler test in
SAS software, used by the previous researcher, at the beginning of this study. Lin
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(2011) suggested that the minimum sample size to be applied to the
Gaussian-Exponential model should be greater than 54 subjects, each with at least
20 observations. However, in this study, most of the simulation results for the
Gaussian-Exponential model attained asymptotic normality as sample size exceeded
18 for both the outcome and time processes. Consequently, the
Gaussian-Exponential model can be valid for data with a sample size of greater
than 18, instead of 54.
Overall, based on the multivariate normality test from the simulation study,
the maximum likelihood parameter estimates of the joint models obtain the
asymptotic normality when sample size is greater than 18. Accordingly, the model
selection methods are valid in the joint models, which are based on the normality
assumption of parameter estimates. For those reasons, the extended joint models
can be recommended to use when sample size is greater than 18. In addition, the
maximum likelihood parameter estimates of the joint models obtain asymptotic
multivariate normality in both balanced and unbalanced designs.
The joint models presented in this study rely on the relation among the
one-step prior outcome, current time, and potential covariates. Also, it is assumed
that time and covariates are independent of each other, and that time should be
informative and exponentially distributed. If any of these assumptions is not
satisfied, the joint models proposed in this study should be considered with caution.
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Application of the Joint Models
The proposed joint models were applied to real datasets to demonstrate the
performance of the models. The Poisson-Exponential model was compared with the
latent effect model proposed by Cai et al. (2012). The results based on the model
of Cai et al. (2012) showed similar findings, for the estimation of the effects of the
treatment and the number of initial tumors. As can be seen in Table 15 and 16,
both methods found that the treatment has a negative effect on the tumor
occurrence, and that the number of initial tumors has a positive effect on the tumor
occurrence. The difference is that the model of Cai et al. (2012) computed the
overall treatment effect, ignoring the effect of each treatment level. However, the
Poisson-Exponential model calculated the estimator for each treatment level, like
other regression analyses normally do. Cai et al. (2012) stated that the treatment
has a negative association since “the more often the patients visited the clinic and
received the treatment, the less chance they will have tumor recurrence” (p. 10).
This interpretation makes sense, but does not specify which treatment is most
effective to reduce the tumor occurrence. However, the Poisson-Exponential model
specifically pointed out that the thiotep treatment only can reduce the tumor
occurrence.
Discussions
In this study, the asymptotic multivariate normality of the maximum
likelihood estimators of the joint models has been verified by simulation studies
with the arbitrary chosen simulation designs. Proving the asymptotic normality
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with mathematical theories is beyond the scope of the current study. This
undeveloped step can be studied by a theorist in the future.
As described in the last paragraph of the previous section, the joint models
have multiple assumptions, which limit the use of the joint models. If those
assumptions are relaxed, the joint models can be easily expanded to be more
flexible.
For example, firstly, the current response is assumed to be dependent upon
the one-step prior outcome. In some experiments, it is possible that the current
response depends on the two-step prior outcome or three-step prior outcome, etc.
In that case, the joint models can be modified to accommodate those terms in the
models by simply replacing yt−1 by yt−2 or yt−3. Secondly, time is assumed to follow
an exponential distribution. The distribution of time can be different based on a
research design, for example, a normal distribution. If that is the situation, the
appropriate distribution can be applied to the time process; then, the maximum
likelihood parameter estimates from the time process can be obtained. Thirdly,
currently time and covariates are assumed to be independent of each other. If they
are related, another term can be added to define the relations between them in the
models. Fourthly, the current joint models have a single response variable in a data
set. If multiple response variables are included in the analysis, the joint models
should be able to take correlations among those into account; furthermore, the joint
models should be able to give simultaneous tests for separate responses, in addition
to a single responses analysis. All of assumption relaxations mentioned above are
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technically possible and can be further explored by a researcher in order to improve
the joint models.
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Appendix A
OUTPUT OF THE BERNOULLI-EXPONENTIAL MODEL
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Bladder Cancer Data
This analysis uses the status variable, “event”, as a outcome, “rx” as a grouping
variable, and “number” and “size” as covariates. This dataset consists of 85
patients.
1. id: Patient id
2. event: Recurrence of tumors (1 = recurrence and 0 = everything else)
3. rx: Treatment 1=placebo 2=thiotepa
4. number: Initial number of tumors (8 = 8 or more)
5. size: Size (cm) of the largest initial tumor
6. stop: Recurrence or censoring time
7. enum: Which recurrence (up to 4)
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Model 1 : event ∼ rx+ number + size
$Model
[1] "Call: event ~ rx + number + size"
$Coefficients Estimate Std. error t value Pr(> t)
(Intercept) -0.05502464 0.24446703 -0.2250800 8.219170e-01
rx2 0.27649473 0.21521080 1.2847623 1.988754e-01
number -0.05055372 0.05694457 -0.8877707 3.746641e-01
size 0.05607314 0.07282951 0.7699233 4.413454e-01
prior.outcome 4.34943175 0.58220294 7.4706455 7.980240e-14
current.time -0.14184232 0.02058932 -6.8891199 5.613863e-12
alpha -3.38082136 0.07960693 -42.4689304 0.000000e+00
delta 0.20276751 0.12872836 1.5751581 1.152200e-01
$AIC
[1] 2652.851
$AICc
[1] 2654.745
$BIC
[1] 2672.392
$LogLik
[1] 199.1082
$LogLikPval
[1] 0
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Model 2 : event ∼ rx+ number
$Model
[1] "Call: event ~ rx + number"
$Coefficients Estimate Std. error t value Pr(> t)
(Intercept) 0.07737720 0.17404807 0.4445737 6.566278e-01
rx2 0.27293430 0.21504153 1.2692167 2.043638e-01
number -0.05978083 0.05571470 -1.0729812 2.832795e-01
prior.outcome 4.33597152 0.57614103 7.5258856 5.236416e-14
current.time -0.14179764 0.02035379 -6.9666444 3.245898e-12
alpha -3.38082133 0.07977955 -42.3770393 0.000000e+00
delta 0.20276748 0.12856084 1.5772103 1.147471e-01
$AIC
[1] 2651.446
$AICc
[1] 2652.901
$BIC
[1] 2668.545
$LogLik
[1] 198.5126
$LogLikPval
[1] 0
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Model 3 : event ∼ rx+ size
$Model
[1] "Call: event ~ rx + size"
$Coefficients Estimate Std. error t value Pr(> t)
(Intercept) -0.17922106 0.20141067 -0.8898290 3.735577e-01
rx2 0.25728127 0.21496375 1.1968589 2.313616e-01
size 0.06963772 0.07131094 0.9765363 3.287988e-01
prior.outcome 4.34895831 0.56927249 7.6395020 2.180635e-14
current.time -0.14216743 0.02026683 -7.0147848 2.303031e-12
alpha -3.38082134 0.07954964 -42.4995167 0.000000e+00
delta 0.20276751 0.12837268 1.5795223 1.142163e-01
$AIC
[1] 2651.641
$AICc
[1] 2653.095
$BIC
[1] 2668.739
$LogLik
[1] 198.3183
$LogLikPval
[1] 0
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Model 4 : event ∼ rx
$Model
[1] "Call: event ~ rx"
$Coefficients Estimate Std. error t value Pr(> t)
(Intercept) -0.03676028 0.13805297 -0.2662767 7.900261e-01
rx2 0.24806938 0.21487572 1.1544784 2.483041e-01
prior.outcome 4.33127194 0.60620489 7.1448977 9.006294e-13
current.time -0.14218783 0.02123201 -6.6968610 2.129440e-11
alpha -3.38082134 0.07983721 -42.3464353 0.000000e+00
delta 0.20276751 0.12875661 1.5748124 1.152997e-01
$AIC
[1] 2650.602
$AICc
[1] 2651.679
$BIC
[1] 2665.258
$LogLik
[1] 197.3565
$LogLikPval
[1] 0
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Appendix B
OUTPUT OF THE POISSON-EXPONENTIAL MODEL
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Bladder1 Cancer Data
This analysis uses “rtumor” as a outcome, “treatment” as a grouping variable, and
“number” and “size” as covariates. This dataset consists of 118 patients.
1. id: Patient id
2. treatment: Placebo, pyridoxine (vitamin B6), or thiotepa
3. number: Initial number of tumors (8 = 8 or more)
4. size: Size (cm) of the largest initial tumor
5. recur: Number of recurrences
6. start: The start time of each time interval
7. stop: The end time of each time interval
8. status: End of interval code, 0 = censored, 1 = recurrence, 2 = death from
bladder disease, 3 = death other/unknown cause
9. rtumor: Number of tumors found at the time of a recurrence
10. rsize: Size of largest tumor at a recurrence
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Model 1 : rtumor ∼ treatment+ number + size
$Model
[1] "Call: rtumor ~ treatment + number + size"
$Coefficients Estimate Std. error t value Pr(> t)
(Intercept) 1.0028856783 0.098013784 10.2320882 1.424149e-24
treatmentpyridoxine -0.0059002387 0.101527477 -0.0581147 9.536573e-01
treatmentthiotepa -0.3009050218 0.126373379 -2.3810792 1.726200e-02
number 0.0087449771 0.022726800 0.3847870 7.003952e-01
size -0.0271937970 0.024349235 -1.1168235 2.640698e-01
prior.outcome 0.0769869072 0.018345161 4.1965785 2.709775e-05
current.time 0.0007712331 0.003072309 0.2510272 8.017931e-01
alpha -3.1450823925 0.150181259 -20.9419099 2.223643e-97
delta -0.0110809301 0.040064259 -0.2765789 7.821034e-01
$AIC
[1] 2220.327
$AICc
[1] 2223.788
$BIC
[1] 2239.471
$LogLik
[1] 45.50186
$LogLikPval
[1] 3.719609e-08
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Model 2 : rtumor ∼ treatment+ number
$Model
[1] "Call: rtumor ~ treatment + number"
$Coefficients Estimate Std. error t value Pr(> t)
(Intercept) 0.9328033958 0.075831065 12.30107206 8.937990e-35
treatmentpyridoxine -0.0100911560 0.101561128 -0.09936042 9.208521e-01
treatmentthiotepa -0.3001890441 0.126609851 -2.37097699 1.774114e-02
number 0.0160542137 0.021800670 0.73640918 4.614817e-01
prior.outcome 0.0784415210 0.018306650 4.28486490 1.828503e-05
current.time 0.0006219553 0.003059826 0.20326490 8.389280e-01
alpha -3.1450823966 0.150016250 -20.96494482 1.370798e-97
delta -0.0110809300 0.040020304 -0.27688270 7.818702e-01
$AIC
[1] 2219.597
$AICc
[1] 2222.314
$BIC
[1] 2236.614
$LogLik
[1] 44.23187
$LogLikPval
[1] 2.078272e-08
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Model 3 : rtumor ∼ treatment+ size
$Model
[1] "Call: rtumor ~ treatment + size"
$Coefficients Estimate Std. error t value Pr(> t)
(Intercept) 1.0273170858 0.074565269 13.77742079 3.485021e-43
treatmentpyridoxine -0.0055632814 0.101657424 -0.05472578 9.563569e-01
treatmentthiotepa -0.2885945888 0.122187411 -2.36190116 1.818149e-02
size -0.0298282354 0.023377995 -1.27591075 2.019871e-01
prior.outcome 0.0769599487 0.018326143 4.19946234 2.675495e-05
current.time 0.0007911878 0.003071865 0.25755945 7.967469e-01
alpha -3.1450824118 0.150107129 -20.95225208 1.789646e-97
delta -0.0110809278 0.040013072 -0.27693270 7.818318e-01
$AIC
[1] 2218.474
$AICc
[1] 2221.191
$BIC
[1] 2235.492
$LogLik
[1] 45.35418
$LogLikPval
[1] 1.229156e-08
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Model 4 : rtumor ∼ treatment
$Model
[1] "Call: rtumor ~ treatment"
$Coefficients Estimate Std. error t value Pr(> t)
(Intercept) 0.9679454154 0.058686375 16.49352880 4.083858e-61
treatmentpyridoxine -0.0096904843 0.101409612 -0.09555785 9.238717e-01
treatmentthiotepa -0.2747982336 0.121497045 -2.26176887 2.371169e-02
prior.outcome 0.0786729618 0.018264445 4.30743786 1.651565e-05
current.time 0.0006277268 0.003056412 0.20538030 8.372750e-01
alpha -3.1450823926 0.150789979 -20.85737002 1.306619e-96
delta -0.0110809306 0.040152939 -0.27596810 7.825726e-01
$AIC
[1] 2218.136
$AICc
[1] 2220.21
$BIC
[1] 2233.026
$LogLik
[1] 43.69226
$LogLikPval
[1] 7.432897e-09
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Appendix C
R PROGRAM FOR SIMULATIONS
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1. Gaussian-Exponential Model
##################################################################
# Packages #
##################################################################
install.packages(’MVN’) # hzTest, roystonTest
install.packages(’MASS’)
install.packages(’maxLik’) #maxLik
install.packages(’AlgDesign’) # gen.factorial
install.packages(’mefa’) # provide rep(dat,times)
library(MVN)
library(MASS)
library(maxLik)
library(AlgDesign)
library(mefa)
##################################################################
# Parameter Setting (Pscheme: 1 to 6) #
##################################################################
parameter = matrix(c(1,1,2,2,0.5,0.5, #1:sigma
0.4,0.4,0.4,0.4,0.4,0.4, #2:beta0
0.2,0.2,0.2,0.2,0.2,0.2, #3:beta1
0.3,0.3,0.3,0.3,0.3,0.3, #4:beta2
0.1,0.1,0.1,0.1,0.1,0.1, #5:beta3
0.3,0.3,0.3,0.3,0.3,0.3, #6:beta4
0.4,0.4,0.4,0.4,0.4,0.4, #7:beta5
0.9,0.9,0.9,0.9,0.9,0.9, #8:beta6
0.8,0.8,0.8,0.0,0.0,0.8, #9:phi
0.1,0.1,0.1,0.1,0.1,0.1, #10:gamma
2,1,2,1,2,1, #11:alpha
0.01,0.02,0.01,0.02,0.01,0.02),#12:delta
nrow=6)
################################################################
# create design matrix (X) with two cat & two cont vars #
################################################################
design=function(level=c(3,3),m=18,p=2){
catg=gen.factorial(levels=level,center=FALSE,factors=’all’)
ext=rep(catg,m/(prod(level)))
des=model.matrix(~.,data=ext) #’~.’ is supported by {AlgDesign}
cont=data.frame(matrix(NA,nrow=m,ncol=p))
112
for (i in 1:p){
cont[i]=rnorm(m)
}
xmatrix=as.matrix(cbind(des,cont))
xmatrix
}
################################################################
# Create Data: c(’outcome’,’time’,’subject’) #
################################################################
outcome<- function(m=m,num=num,parm=parm){
if (num == 1) {n1 = 10; n2=10}
if (num == 2) {n1 = 5; n2=3}
if (num == 3) {n1 = 10; n2=5}
if (num == 4) {n1 = 20; n2=6}
ndesign = matrix(c(rep(n1,m/2),rep(n2,m/2)),byrow=T)
nn=cumsum(c(1,ndesign[-length(ndesign)]))
raw = matrix(NA,sum(ndesign),3) #Null matrix
mu = xmatrix %*% parm[2:8] # mu is matrix
raw[nn,1]= mu + rnorm(m)*parm[1]
raw[nn,2] = rexp(m)
for (i in 1:m){
for (j in 2:ndesign[i]){
yjmin1 = raw[nn[i] - 1 + j - 1,1]
raw[nn[i] - 1 + j,2] = rexp(1)*
exp(parm[11] +parm[12] * yjmin1)
raw[nn[i] - 1 + j,1] =mu[i] + yjmin1 * parm[9] +
raw[nn[i]-1+j,2]*parm[10]+rnorm(1)*parm[1]
raw[nn[i],3]=i
raw[nn[i]-1+j,3]=i
} #j
}#i
result=list(raw=raw,nn=nn,ndesign=ndesign)
result
} #outcome
###########################################################
# Log-Likelihood Function #
###########################################################
loglikfn<- function(parms){
113
y1=y[nn,1] #initial obs for every subjects
f1=sum(-0.5 * log(parms[1]^2)-0.5*
(y1-xmatrix %*% parms[2:8])^2/parms[1]^2)
f2=0;f3=0
for (i in 1:m){
yi=y[(y[,3]==i), 1] # all obs for ith subject
ti=y[(y[,3]==i), 2] # all time points for ith subject
yi1=yi[-ndesign[i]] #previous obs
tti=ti[-1] #current time
yi2=yi[-1] #current obs
f2=sum(-0.5 * log(parms[1]^2)-0.5 *
(yi2-parms[10]*tti-parms[9]*yi1-xmatrix[i,]%*%parms[2:8])^2/
parms[1]^2)+f2
f3=sum(parms[11]+parms[12]*yi1-
exp(parms[11]+parms[12]*yi1)*tti)+f3
} #i
(m+f1+f2+f3)
} # loglike
##########################################################
# Simulation #
##########################################################
Pschem = 1 # parameter setting, 1 to 6
m=36
num = 2 # design structure 1(10,10), 2(5,3),3(10,5),4(20,6)
rep=1000 #number of replications
out = matrix(NA,rep,ncol(parameter))
parm = parameter[Pschem,]
xmatrix=design(level=c(3,3),m=m,p=2)
for (r in 1:rep){
#compute some info to be used in optimization
result=outcome(m=m,num=num,parm=parm)
y=result$raw
nn=result$nn
ndesign=result$ndesign
mle=maxLik(logLik = loglikfn, start = parm)
diff=coef(mle)-parm
out[r,]=sqrt(sum(ndesign))*diff/summary(mle)$estimate[,2]
}
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hzTest(out[,1:9]) #Outcome process
hzTest(out[,10:11]) #Time process
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2. Bernoulli-Exponential Model
##################################################################
# Parameter Setting (Pscheme: 1 to 6) #
##################################################################
parameter = matrix(c(0.4,0.4,0.4,0.4,0.4,0.4, #1:beta0
0.2,0.2,0.2,0.2,0.2,0.2, #2:beta1
0.3,0.3,0.3,0.3,0.3,0.3, #3:beta2
0.1,0.1,0.1,0.1,0.1,0.1, #4:beta3
0.3,0.3,0.3,0.3,0.3,0.3, #5:beta4
0.4,0.4,0.4,0.4,0.4,0.4, #6:beta5
0.9,0.9,0.9,0.9,0.9,0.9, #7:beta6
0.8,0.8,0.8,0.0,0.0,0.8, #8:phi
0.1,0.1,0.1,0.1,0.1,0.1, #9:gamma
2,1,2,1,2,1, #10:alpha
0.01,0.02,0.01,0.02,0.01,0.02),#11:delta
nrow=6)
################################################################
# Create Data: c(’outcome’,’time’,’subject’) #
################################################################
outcome<- function(m=m,num=num,parm=parm){
if (num == 1) {n1 = 10; n2=10}
if (num == 2) {n1 = 5; n2=3}
if (num == 3) {n1 = 10; n2=5}
if (num == 4) {n1 = 20; n2=6}
ndesign = matrix(c(rep(n1,m/2),rep(n2,m/2)),byrow=T)
nn=cumsum(c(1,ndesign[-length(ndesign)]))
raw = matrix(NA,sum(ndesign),3) #Null matrix
mu=xmatrix %*% parm[1:7]
raw[nn,1]=rbinom(m,1,ui1)
raw[nn,2] = rexp(m,rate=1)
for (i in 1:m){
for (j in 2:ndesign[i]){
yjmin1 = raw[nn[i]-1+j-1,1]
raw[nn[i]-1+j,2]= rexp(1)*exp(parm[10]+parm[11]*yjmin1)
uij=1/(1+exp(-(mu[i]+raw[nn[i]-1+j,2]*parm[9]+yjmin1 * parm[8])))
raw[nn[i]-1+j,1]=rbinom(1,1,uij)
raw[nn[i],3]=i
raw[nn[i]-1+j,3]=i
} #j
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}#i
result=list(raw=raw,nn=nn,ndesign=ndesign)
result
} #outcome
###########################################################
# Log-Likelihood Function #
###########################################################
loglikfn<-function(parms){
y1=y[nn,1] #initial obs for every subjects
mu=xmatrix %*% parms[1:7]
ui1=1/(1+exp(-mu))
f1=sum(y1*log(ui1/(1-ui1))+log(1-ui1))
f2=0;f3=0
for(i in 1:m){
yi=y[(y[,3]==i), 1] # all obs for ith subject
ti=y[(y[,3]==i), 2] # all time points for ith subject
yi1=yi[-ndesign[i]] #previous obs
tti=ti[-1] #current time
yi2=yi[-1] #current obs
uij=1/(1+exp(-(mu[i]+parms[9]*tti+parms[8]*yi1)))
f2=sum((1-yi2)*log(1-uij)+ yi2*log(uij))+f2
f3=sum(parms[10]+parms[11]*yi1-
exp(parms[10]+parms[11]*yi1)*tti)+f3
} #i
(m+f1+f2+f3)
} #loglikfn
##########################################################
# Simulation #
##########################################################
Pschem = 1 # parameter setting, 1 to 6
m=36
num = 2 # design structure 1(10,10), 2(5,3),3(10,5),4(20,6)
rep=1000 #number of replications
out = matrix(NA,rep,ncol(parameter))
parm = parameter[Pschem,]*0.1
xmatrix=design(level=c(3,3),m=m,p=2)
for (r in 1:rep){
result=outcome(m=m,num=num,parm=parm)
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y=result$raw
nn=result$nn
ndesign=result$ndesign
mle=maxLik(logLik = loglikfn, start = parm)
diff=coef(mle)-parm
out[r,]=sqrt(sum(ndesign))*diff/summary(mle)$estimate[,2]
}
hzTest(out[,1:9]) #Outcome process
hzTest(out[,10:11]) #Time process
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3. Poisson-Exponential Model
##################################################################
# Parameter Setting (Pscheme: 1 to 6) #
##################################################################
parameter = matrix(c(0.4,0.4,0.4,0.4,0.4,0.4, #1:beta0
0.2,0.2,0.2,0.2,0.2,0.2, #2:beta1
0.3,0.3,0.3,0.3,0.3,0.3, #3:beta2
0.1,0.1,0.1,0.1,0.1,0.1, #4:beta3
0.3,0.3,0.3,0.3,0.3,0.3, #5:beta4
0.4,0.4,0.4,0.4,0.4,0.4, #6:beta5
0.9,0.9,0.9,0.9,0.9,0.9, #7:beta6
0.8,0.8,0.8,0.0,0.0,0.8, #8:phi
0.1,0.1,0.1,0.1,0.1,0.1, #9:gamma
2,1,2,1,2,1, #10:alpha
0.01,0.02,0.01,0.02,0.01,0.02),#11:delta
nrow=6)
################################################################
# Create Data: c(’outcome’,’time’,’subject’) #
################################################################
outcome<- function(m=m,num=num,parm=parm){
if (num == 1) {n1 = 10; n2=10}
if (num == 2) {n1 = 5; n2=3}
if (num == 3) {n1 = 10; n2=5}
if (num == 4) {n1 = 20; n2=6}
ndesign = matrix(c(rep(n1,m/2),rep(n2,m/2)),byrow=T)
nn=cumsum(c(1,ndesign[-length(ndesign)]))
raw = matrix(NA,sum(ndesign),3) #Null matrix
mu=xmatrix %*% parm[1:7]
ui1=exp(mu)
raw[nn,1]=rpois(m,ui1)
raw[nn,2] = rexp(m)
for (i in 1:m){
for (j in 2:ndesign[i]){
yjmin1 = raw[nn[i]-1+j-1,1]
raw[nn[i]-1+j,2]= rexp(1)*(exp(parm[10]+parm[11]*yjmin1))
uij=exp(mu[i]+raw[nn[i]-1+j,2]*parm[9]+yjmin1*parm[8])
raw[nn[i]-1+j,1]=rpois(1,uij)
raw[nn[i],3]=i
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raw[nn[i]-1+j,3]=i
} #j
}#i
result=list(raw=raw,nn=nn,ndesign=ndesign)
result
} #outcome
###########################################################
# Log-Likelihood Function #
###########################################################
loglikfn<- function(parms){
y1=y[nn,1] #initial obs for every subjects
mu=xmatrix %*% parms[1:7]
ui1=exp(mu)
f1=sum(y1*log(ui1)-ui1-log(factorial(y1)))
f2=0;f3=0
for( i in 1:m){
yi=y[(y[,3]==i), 1] # all obs for ith subject
ti=y[(y[,3]==i), 2] # all time points for ith subject
yi1=yi[-ndesign[i]] #previous obs
tti=ti[-1] #current time
yi2=yi[-1] #current obs
uij=exp(mu[i]+parms[9]*tti+parms[8]*yi1)
f2=sum(yi2*log(uij)-uij-log(factorial(yi2)))+f2
f3=sum(parms[10]+parms[11]*yi1-exp(parms[10]+parms[11]*yi1)*tti)+f3
} #i
(m+f1+f2+f3)
} #loglikfn
##########################################################
# Simulation #
##########################################################
Pschem = 1 # parameter setting, 1 to 6
m=36
num = 2 # design structure 1(10,10), 2(5,3),3(10,5),4(20,6)
rep=1000 #number of replications
out = matrix(NA,rep,ncol(parameter))
parm = parameter[Pschem,]*0.1
xmatrix=design(level=c(3,3),m=m,p=2)
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for (r in 1:rep){
result=outcome(m=m,num=num,parm=parm)
y=result$raw
nn=result$nn
ndesign=result$ndesign
mle=maxLik(logLik = loglikfn, start = parm)
diff=coef(mle)-parm
out[r,]=(sqrt(sum(ndesign))*diff)/summary(mle)$estimate[,2]
}
hzTest(out[,1:9]) #Outcome process
hzTest(out[,10:11]) #Time process
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4. Gamma-Exponential Model
##################################################################
# Parameter Setting (Pscheme: 1 to 6) #
##################################################################
parameter = matrix(c(10,10,10,12,12,12, #1:v
0.4,0.4,0.4,0.4,0.4,0.4, #2:beta0
0.2,0.2,0.2,0.2,0.2,0.2, #3:beta1
0.3,0.3,0.3,0.3,0.3,0.3, #4:beta2
0.1,0.1,0.1,0.1,0.1,0.1, #5:beta3
0.3,0.3,0.3,0.3,0.3,0.3, #6:beta4
0.4,0.4,0.4,0.4,0.4,0.4, #7:beta5
0.9,0.9,0.9,0.9,0.9,0.9, #8:beta6
0.8,0.8,0.8,0.0,0.0,0.8, #9:phi
0.1,0.1,0.1,0.1,0.1,0.1, #10:gamma
2,1,2,1,2,1, #11:alpha
0.01,0.02,0.01,0.02,0.01,0.02),#12:delta
nrow=6)
################################################################
# Create Data: c(’outcome’,’time’,’subject’) #
################################################################
outcome<- function(m=m,num=num,parm=parm){
if (num == 1) {n1 = 10; n2=10}
if (num == 2) {n1 = 5; n2=3}
if (num == 3) {n1 = 10; n2=5}
if (num == 4) {n1 = 20; n2=6}
ndesign = matrix(c(rep(n1,m/2),rep(n2,m/2)),byrow=T)
nn=cumsum(c(1,ndesign[-length(ndesign)]))
raw = matrix(NA,sum(ndesign),3) #Null matrix
mu=xmatrix %*% parm[2:8]
ui1=exp(mu)
raw[nn,1]=rgamma(n=m,shape=ui1*parm[1],scale=parm[1])
raw[nn,2] = rexp(m)
for (i in 1:m){
for (j in 2:ndesign[i]){
yjmin1 = raw[nn[i]-1+j-1,1]
raw[nn[i]-1+j,2]= rexp(1)*(exp(parm[11]+parm[12]*yjmin1))
uij=exp(mu[i]+raw[nn[i]-1+j,2]*parm[10]+yjmin1*parm[9])
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raw[nn[i]-1+j,1]=rgamma(1,shape=uij*parm[1],scale=parm[1])
raw[nn[i],3]=i
raw[nn[i]-1+j,3]=i
} #j
}#i
result=list(raw=raw,nn=nn,ndesign=ndesign)
result
} #outcome
###########################################################
# Log-Likelihood Function #
###########################################################
loglikfn<- function(parms){
y1=y[nn,1] #initial obs for every subjects
mu=xmatrix %*% parms[2:8]
ui1=exp(mu)
f1=sum((-y1/ui1-log(ui1))*parms[1]+parms[1]*log(parms[1])+
(parms[1]-1)*log(y1)-log(gamma(parms[1])))
f2=0;f3=0
for(i in 1:m){
yi=y[(y[,3]==i), 1] # all obs for ith subject
ti=y[(y[,3]==i), 2] # all time points for ith subject
yi1=yi[-ndesign[i]] #previous obs
tti=ti[-1] #current time
yi2=yi[-1] #current obs
uij=exp(mu[i]+parms[10]*tti+parms[9]*yi1)
f2=sum((-yi2/uij-log(uij))*parms[1]+parms[1]*log(parms[1])+
(parms[1]-1)*log(yi2)-log(gamma(parms[1])))+f2
f3=sum(parms[11]+parms[12]*yi1-
exp(parms[11]+parms[12]*yi1)*tti)+f3
} #i
(m+f1+f2+f3)
} #loglikfn
##########################################################
# Simulation #
##########################################################
Pschem = 1 # parameter setting, 1 to 6
m=18
num = 2 # design structure 1(10,10), 2(5,3),3(10,5),4(20,6)
rep=1000 #number of replications
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out = matrix(NA,rep,ncol(parameter))
parm = parameter[Pschem,]*0.1
xmatrix=design(level=c(3,3),m=m,p=2)
for (r in 1:rep){
result=outcome(m=m,num=num,parm=parm)
y=result$raw
nn=result$nn
ndesign=result$ndesign
mle=maxLik(logLik = loglikfn, start = parm)
diff=coef(mle)-parm
out[r,]=sqrt(sum(ndesign))*diff/summary(mle)$estimate[,2]
}
hzTest(out[,1:9]) #Outcome process
hzTest(out[,10:11]) #Time process
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Appendix D
R PROGRAM OF THE JOINT MODELS
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##################################################################
# Joint Model
##################################################################
# DESCRIPTION:
# JointModel is used to fit longitudinal outcomes and informative
# time under the assumptions that the current outcome is dependent
# on the one-step prior outcome, and that time follows an
# exponential distribution. The outcome distributions that can be
# analyzed by this function are the Gaussian, Bernoulli, Poisson,
# and Gamma distributions. The function computes the effects of
# the prior outcome, current time, alpha, and delta; therefore,
# these terms do not need to be specified in the model.
#
# USAGE:
# JointModel(formula, data, id, time, family, link = log)
# - formula: a symbolic description of the model to be fitted.
# - data: dataset name to be analyzed
# - id: id variable name in the dataset to be analyzed
# - time: time variable name in a dataset to be analyzed
# - family: distribution of outcome variable,
# such as gaussian, bernoulli, poisson, and gamma.
# - link: name of the link function. The default link function
# for gaussian is identity, logit for bernoulli, log for
# poisson and gamma. The inverse or identify can be used
# for gamma.
###################################################################
########################################################
# A Example of Data Structure to be analyzed
########################################################
# data with two continous vars and one factor
# subj: id, y:outcome, t:time, f1:factor, c1 & c2: continuous vars
#
# subj y t f1 c1 c2
#1 1 0 0.4352370 1 0.13333636 1.08576936
#2 1 0 0.2634203 1 0.13333636 1.08576936
#3 1 1 1.4733225 1 0.13333636 1.08576936
#4 1 1 0.7620299 1 0.13333636 1.08576936
#5 2 0 1.2376036 1 0.80418951 -0.69095384
#6 2 1 4.4239342 1 0.80418951 -0.69095384
#7 2 1 1.0545432 1 0.80418951 -0.69095384
#8 2 1 1.0352439 1 0.80418951 -0.69095384
#9 3 1 1.8760352 2 -0.05710677 -1.28459935
#10 3 0 0.6547466 2 -0.05710677 -1.28459935
#############################################################
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JointModel <- function(formula, data, id, time, family, link = log) {
wants <- c(’maxLik’, ’formula.tools’, ’MASS’)
has <- wants %in% rownames(installed.packages())
if (any(!has)) install.packages(wants)
library(maxLik)
library(formula.tools)
library(MASS)
arguments <- as.list(match.call())
id <- eval(arguments$id, data)
time <- eval(arguments$time, data)
get.names <- get.vars(formula)
id.time <- data.frame(cbind(id=id,time=time))
df <- data[,get.names]
df <- cbind(id.time, df)
df <- df[complete.cases(df),]
df[,1] <- as.numeric(as.factor(df[,1])) #1=id
xdesign <- model.matrix(formula, data = df)
coef.names <- colnames(xdesign)
ndesign <- as.numeric(table(df[,1])) #1=id
m <- tail(df[,1],1) #1=id
nn <- cumsum(c(1,ndesign[-length(ndesign)]))
df$lag.out <- c(NA, df[-nrow(df), 3])
for (i in 1:(nrow(df)-1)) {
if(df[,1][i]!= df[,1][i+1]) df$lag.out[i+1] <- NA
}
time.initial <- lm(df[,3]~lag.out,data=df) #3=outcome
time.coef <- as.numeric(coef(time.initial))
x.name <- c(get.names[-1],’lag.out’,’df[,2]’)
ff <- as.formula(paste(’df[,3]~’,paste(x.name,collapse=’+’)))
out.initial <- lm(ff,data=df)
out.coef <- as.numeric(coef(out.initial))
if (arguments$family == ’poisson’| arguments$family== ’bernoulli’) {
initial <- c(out.coef, time.coef)
} else if (arguments$family== ’gaussian’) {
initial <- c(out.coef, time.coef, sd(df[,3]))
} else {
v <- fitdistr(df[,3], "Gamma")
127
v <- as.numeric(a$estimate[1])
initial <- c(out.coef,time.coef, v)
}
if(arguments$family== ’gaussian’) {
LikeFn <- function(parms) {
y1= df[nn,as.character(lhs(formula))]
mu=xdesign %*% parms[1:ncol(xdesign)]
f1=sum(-0.5 * log(parms[ncol(xdesign)+5]^2)-0.5*
(y1-mu)^2/parms[ncol(xdesign)+5]^2)
f2=0;f3=0
for (i in 1:m) {
yi=df[(df[,’id’]==i), as.character(lhs(formula))] #1=id
ti=df[(df[,’id’]==i), as.character(lhs(formula))] #1=id
yi1=yi[-ndesign[i]] #previous obs
tti=ti[-1] #current time
yi2=yi[-1] #current obs
f2=sum(-0.5 * log(parms[ncol(xdesign)+5]^2)-0.5 *
(yi2-parms[ncol(xdesign)+2]*tti-parms[ncol(xdesign)+1]*
yi1-mu[i])^2/parms[ncol(xdesign)+5]^2)+f2
f3=sum(parms[ncol(xdesign)+3]+parms[ncol(xdesign)+4]*yi1-
exp(parms[ncol(xdesign)+3]+ parms[ncol(xdesign)+4]*yi1)*tti)+f3
} #i
(m+f1+f2+f3)
} # LikeFn
} #gaussian
if(arguments$family== ’bernoulli’) {
LikeFn <-function(parms) {
y1 <- df[nn, as.character(lhs(formula))]
mu <- xdesign %*% parms[1:ncol(xdesign)]
ui1 <- 1/(1+exp(-mu))
f1 <- sum(y1*(log(ui1)-log(1-ui1))+log(1-ui1))
f2 <- 0; f3 <- 0
for(i in 1:m) {
yi <- df[(df[,’id’]==i), as.character(lhs(formula))] #1=id
ti <- df[(df[,’id’]==i), 2]
yi1 <- yi[-ndesign[i]] #previous obs
tti <- ti[-1] #current time
128
yi2 <- yi[-1] #current obs
uij <- 1/(1+exp(-(mu[i]+parms[ncol(xdesign)+2]*tti+
parms[ncol(xdesign)+1]*yi1)))
f2 <- sum((1-yi2)*log(1-uij)+ yi2*log(uij))+f2
f3 <- sum(parms[ncol(xdesign)+3]+parms[ncol(xdesign)+4]*yi1-
exp(parms[ncol(xdesign)+3]+parms[ncol(xdesign)+4]*yi1)*tti)+f3
} #i
(m+f1+f2+f3)
} #LikeFn
} #binomial
if(arguments$family== ’poisson’) {
LikeFn <- function(parms) {
y1 <- df[nn, as.character(lhs(formula))]
mu <- xdesign %*% parms[1:ncol(xdesign)]
ui1 <- exp(mu)
f1 <- sum(y1*log(ui1)-ui1-log(factorial(y1)))
f2 <- 0; f3 <- 0
for (i in 1:m) {
yi <- df[(df[,’id’]==i), as.character(lhs(formula))]
ti <- df[(df[,’id’]==i), 2] #2=time
yi1 <- yi[-ndesign[i]] #previous obs
tti <- ti[-1] #current time
yi2 <- yi[-1] #current obs
uij <- exp(mu[i]+parms[ncol(xdesign)+2]*tti+
parms[ncol(xdesign)+1]*yi1)
f2 <- sum(yi2*log(uij)-uij-log(factorial(yi2)))+f2
f3 <- sum(parms[ncol(xdesign)+3]+parms[ncol(xdesign)+4]*yi1-
exp(parms[ncol(xdesign)+3]+
parms[ncol(xdesign)+4]*yi1)*tti)+f3
} #i
(m+f1+f2+f3)
} #LikeFn
} #poisson
if(arguments$family== ’gamma’) {
LikeFn <-function(parms) {
y1 <- df[nn, as.character(lhs(formula))]
mu <- xdesign %*% parms[1:ncol(xdesign)]
ui1 <- exp(mu)
if (arguments$link ==’inverse’) ui1 <- 1/mu
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if (arguments$link ==’indentity’) ui1 <- mu
f1 <- sum((-y1/ui1-log(ui1))*parms[ncol(xdesign)+5]+
parms[ncol(xdesign)+5]*log(parms[ncol(xdesign)+5])+
(parms[ncol(xdesign)+5]-1)*log(y1)-
log(gamma(parms[ncol(xdesign)+5])))
f2 <- 0; f3 <- 0
for (i in 1:m) {
yi <- df[(df[,’id’]==i), as.character(lhs(formula))]
ti <- df[(df[,’id’]==i), time]
yi1 <- yi[-ndesign[i]] #previous obs
tti <- ti[-1] #current time
yi2 <- yi[-1] #current obs
uij <- exp(mu[i]+parms[ncol(xdesign)+2]*tti+
parms[ncol(xdesign)+1]*yi1)
if (arguments$link==’inverse’) uij <- 1/uij
if (arguments$link==’indentity’) uij <- uij
f2 <- sum((-yi2/uij-log(uij))*parms[ncol(xdesign)+5]+
parms[ncol(xdesign)+5]*log(parms[ncol(xdesign)+5])+
(parms[ncol(xdesign)+5]-1)*log(yi2)-
log(gamma(parms[ncol(xdesign)+5])))+f2
f3 <- sum(parms[ncol(xdesign)+3]+parms[ncol(xdesign)+4]*yi1-
exp(parms[ncol(xdesign)+3]+
parms[ncol(xdesign)+4]*yi1)*tti)+f3
} #i
(m+f1+f2+f3)
} #LikeFn
} #gamma
if(arguments$family== ’gamma’) {
mlefull <- maxLik(logLik=LikeFn,start=initial)
betas <- c(coef.names, ’prior.outcome’,’current.time’,
’alpha’,’delta’,’shape’)
names(mlefull$estimate) <- betas
mlered <- maxLik(logLik=LikeFn,
start=c(initial[1],rep(0,ncol(xdesign)+3),v),
activePar=c(T,rep(F,ncol(xdesign)+1),rep(T,2),T)
)
} else if (arguments$family==’gaussian’) {
mlefull <- maxLik(logLik=LikeFn,start=initial)
betas <- c(coef.names,’prior.outcome’,’current.time’,
’alpha’,’delta’,’sigma’)
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names(mlefull$estimate) <- betas
mlered <- maxLik(logLik=LikeFn,
start=c(initial[1],rep(0,ncol(xdesign)+3),
initial[length(initial)]),
activePar=c(T,rep(F,ncol(xdesign)+1), rep(T,2),T)
)
} else {
mlefull <- maxLik(logLik=LikeFn,start=initial)
betas <- c(coef.names,’prior.outcome’,’current.time’,’alpha’,’delta’)
names(mlefull$estimate) <- betas
mlered <- maxLik(logLik=LikeFn,
start=c(initial[1],rep(0,ncol(xdesign)+3)),
activePar=c(T,rep(F,ncol(xdesign)+1), rep(T,2))
)
}
parm <- summary(mlefull)
est <- summary(mlefull)$estimate
AIC <- AIC(mlefull)
AICc <- AIC+2*parm$NActivePar*(parm$NActivePar+1)/
(m-parm$NActivePar-1)
BIC <- -2*parm$loglik+parm$NActivePar*log(m)
ratio <- 2*(logLik(mlefull)-logLik(mlered))
dfred <- summary(mlered)$NActivePar
dffull <- summary(mlefull)$NActivePar
dfchi <- dffull-dfred
Pr <- 1-pchisq(ratio,dfchi)
list(Model = paste(’Call: ’, formula )),
Coefficients = est,
AIC = AIC, AICc = AICc, BIC = BIC,
LogLik = ratio, LogLikPval = Pr)
} #JointModel
